Welcome to SRM Centre for Clinical Trials and Research (SRM-CCTR): We Probe, We Prove
Embark on a journey of discovery and progress with SRM-CCTR, a leading clinical trial and research facility dedicated to advancing healthcare through cutting-edge studies. Our commitment to excellence has earned us the trust of the world’s leading pharmaceutical companies and premier clinical research organizations. With state-of-the-art facilities, unwavering quality, meticulous selection processes, and a team of experts, SRM-CCTR is your dependable partner for transformative clinical research. We are thrilled to announce that SRM-CCTR has received approval from the Indian Council for Medical Research (ICMR) to conduct Phase 1 drug trials. This recognition underscores our dedication to pushing the boundaries of medical research and contributing to the development of ground breaking therapeutic solutions.
Clinical Trials Expertise:
Navigate the diverse landscape of clinical trials confidently with our comprehensive approach covering Phases I to IV and Post-Marketing Surveillance Studies. Ensure the reliability and accuracy of medical devices and diagnostics through our specialized validation studies. Explore pharmaceutical product bioequivalence with our expertise in BA BE Studies.
Academic Trials and Research:
Leverage our advanced capabilities for in-depth analysis of biological samples in Biochemistry, Proteomics, and pharmcogenomics. Foster academic exploration and innovation with our support for Investigator Initiated Trials. Craft the foundation of meaningful scientific inquiry through robust protocol development for research questions. Elevate the quality of academic publications with our comprehensive editorial and support services, including Literature Reviews, Authoring, Grant Writing, Editing and proofreading manuscripts.
Join SRM-CCTR in our mission to reshape the future of healthcare through ground breaking research and clinical trials. Contact us today to explore collaboration opportunities and contribute to a healthier world.
Disclaimer: SRM-CCTR conducts all studies in strict compliance with applicable regulatory guidelines and protocols, upholding the highest standards of ethical conduct in clinical research
We are a fully integrated pure-play biologics Contract Development and Manufacturing Organization (CDMO), offering the complete spectrum of services, from cell line technology transfer to clinical and commercial manufacturing with capabilities to convert drug substance into stable formulations and fill and finish formats. We have proven technical expertise in microbial, mammalian, viral vectors, and various other technology platforms with world-class cGMP manufacturing facilities that offer high-quality services for your global programs.
At Clarivate Life Sciences and Healthcare, our goal is to empower our customers to create a healthier tomorrow. We provide data, deep expertise and intelligence platforms to enable our customers to deliver safe, effective and commercially successful treatments / solutions to patients faster. Through transformative intelligence, we empower you to anticipate and address healthcare’s biggest challenges in an ever-evolving world. All with the most important person in mind—the patient.
Please check our website to know more about our solutions:
STERIS Life Sciences is your trusted partner in contamination control and infection prevention. For over 100 years, STERIS has been a global leader and expert in the industries of sterilization, cleaning and infection control. From innovation to results, our comprehensive portfolio of products and services is designed to meet your cleaning, disinfection & sterilization needs.
Whether you’re a researcher or manufacturer, STERIS has solutions to help prevent contamination at virtually every critical point in your process. Across the globe, we provide products and services to help create and maintain clean and sterile environments. STERIS Life Sciences is your trusted partner in contamination control and infection prevention.
For over 100 years, STERIS has been a global leader and expert in the industries of sterilization, cleaning and infection control. From innovation to results, our comprehensive portfolio of products and services is designed to meet your cleaning, disinfection & sterilization needs.
Boehringer Ingelheim BioXcellence™ as the contract manufacturing arm of Boehringer Ingelheim, we have built a reputation as a reliable, world-class partner for biopharmaceuticals development and manufacturing. With sites in the USA, Europe, and Asia, we offer a full range of services, backed by 40 years of biotechnology experience.
Email: cdmo.sha@boehringer-ingelheim.
Website: www.bioxcellence.com
Exhibitors Voice is a platform that caters to all your service requirements in the B2B sector. In today’s era, creating a digital impact is necessary. It is essential to understand the mindset of the target audience and apply the proper techniques to get your target audience to approach you.
With Exhibitors Voice, you can do this in several ways – You can contribute articles listing top event organizers, email Greetings, marketing services, banner and webinar marketing and much more. The site is a valuable resource for multiple B2B requirements.
We strive to serve the target audience’s needs worldwide by giving a one- stop solution for resources from multiple industries. The categories included are Automation, Defense, Health care, Pharmaceutical, Chemical, Steel, Army, etc.
Website URL: https://exhibitorsvoice.com
Watson-Marlow Fluid Technology Solutions (WMFTS) is the world leader in niche peristaltic pumps and associated fluid path technologies for the food, pharmaceutical, chemical and environmental industries. Comprising ten established brands, each with their area of expertise, but together offering our customers unrivalled solutions for their pumping and fluid transfer applications.
Our fluid path technologies are engineered to safeguard your product throughout your process. With a comprehensive portfolio of products and assembly design capabilities, we can support your process throughout upstream, downstream and final fill/finish applications.
We partner with you to understand your process at any stage. Research laboratories through bulk drug substance cGMP facilities worldwide choose to partner with us due to our ability to develop their bioprocess.
Partnering with our specialist peristaltic, component and single-use experts means we can develop efficient, reliable fluid transfer solutions, specific to your process. As the only peristaltic pump manufacturer in the world to also manufacture tubing, you can trust the performance of our engineering.
Svar Life Science, a Swedish group of companies, specializes in inventing, developing, and applying the best assay technology for drug development.
We aim to deliver tailored solutions, create practical platforms for routine testing, and share knowledge to enhance competencies through partnerships.
We work to deliver the right answers at the right time to improve and accelerate drug development. We cover the entire drug development value chain, and provide tools and services.
What we do
CRO Services
We offer extensive bioanalytical services often using our in-house products and expertise to streamline the drug development process.
Our approach is customer-centric, supporting Bioanalytical Services, Biomarker Discovery Services, and QC Testing Services. Our GxP-compliant lab ensures collaborative excellence in every project.
Off the shelf Products
We offer a comprehensive portfolio of life science products to support drug development and provide tools for patient management.
We specialize in the development of cell-based assays and tools for assessing the functionality of complement pathways and the quantity of complement Biomarkers. To do so, we provide Mechanism of Action (MoA) cellular assays and immunoassays catering to all phases of drug development, serving commercial labs and research facilities.
Custom Solutions
When standard products fall short, we propose personalized and reliable solutions for your assay development either by tailored cell line development and optimization for your specific target or by developing Ligand-Binding Assays (ELISA, MSD, and SiMoA).
Our cell-based service offering also includes assay-ready cell development and the establishment of master cell banks.
Company Website (URL Link) – www.svarlifescience.com
Etihad Cargo is the cargo and logistics arm of Etihad Airways. Since its establishment in 2004, Etihad Cargo has grown rapidly to become one of the leading air cargo carriers in the world, offering customers a range of cargo products and services via an extensive global network of chartered and scheduled services. The carrier’s Abu Dhabi hub is strategically located at the centre of the world’s busiest trade lanes, providing an integral link between Asia, Europe, North America, Australia and Africa.
Etihad Cargo is proud to be the Air Cargo Partner of Choice, delivering tailored customer experiences and outstanding operational efficiency. In addition to general cargo, Etihad Cargo’s special products and services include SkyStables (Equine), LiveAnimals (pets), PharmaLife (pharma and life sciences), FreshForward (perishables), SecureTech (Electronics), FlightValet (Automobile) , AirMail, SafeGuard and FlyCulture (Vulnerables).
Etihad Cargo have successfully obtained all four IATA Centre of Excellence Validators Certification (CEIV) for Pharma, Fresh, Live Animals and Lithium Batteries.
For more information, please visit www.etihadcargo.com
Bluecrux is a leading value chain technology and consulting company, providing solutions at “the Cutting X”. Bluecrux experts and software help to transform today’s supply chains into smart, efficient, and fully integrated value chains. Bluecrux offers solutions that fit the unique complexities of businesses in life sciences, consumer goods, chemicals and industrial manufacturing.
Our client portfolio includes some of the world’s largest companies, including Johnson & Johnson, GSK, Roche, Bridgestone, AkzoNobel, Beiersdorf, Pfizer, Novartis and many more. Our desire to work closely with them is also reflected in our global presence, with offices in Europe, US and South East Easia.
Want to discover more? www.bluecrux.com
time:matters is a subsidiary of Lufthansa Cargo and specialized in the worldwide transport of urgent and sensitive goods such as R&D samples, urgently needed API’s, clinical trials or radioactive products. With over 20 years of experience, we have extensive knowledge and expertise in the transportation of time- and temperature-sensitive therapies, raw materials, excipients and medical technologies for the diagnosis and treatment of cancer and other diseases. Our focus is on maintaining the integrity of these products throughout the supply chain. We understand the critical nature of time- and temperature-sensitive shipments and take steps to minimize risk and maximize control. We control the entire supply chain with GDP-compliant handling and courier partners, ensuring full control of the entire process – even beyond airport borders. We emphasize on-time delivery and continuous monitoring of shipments to avoid temperature deviations. Our transportation solutions for temperature-controlled shipments range from cryopreserved to room temperature (-190°C to +37 °C). We also offer return logistics for packaging to make the entire process seamless and efficient. Please follow the link for more information: Life & Health time:matters
Siegfried is a globally leading outsourcing partner, providing tailor-made services that seamlessly integrate into the value chain of our customers. We offer contract development and manufacturing of APIs and finished dosage forms. Through our integrated approach we ensure a comprehensive range of services from process development and optimization to registration, production, packaging and logistics.
As a fully integrated CDMO, Siegfried is one of the few organizations today that can carry out the development and manufacturing of APIs and finished dosage forms under one roof. This unique combination of know-how and experience makes us the most trusted partner in the pharmaceutical industry.
Founded in 1873 in Zofingen, Switzerland, today we operate a global network of 12 sites on three continents. Our workforce of approximately 3,600 highly skilled professionals is committed to take the innovations of our pharmaceutical customers to industrial scale and manufacture safe drugs for patients worldwide.
Website URL: Home – Siegfried
BioConnection is a CDMO for the development and manufacturing of injectable (bio)pharmaceutical products (aseptic). Our state-of-the art GMP manufacturing facility in The Netherlands is EMA and US-FDA certified. We have over 18 years of experience and can handle liquid products (incl. suspensions) and freeze-dried products in batch sizes ranging from a few hundred vials (e.g personalized medicine) up to 150,000 vials per batch for clinical or commercial productions.
We offer complete drug product (DP) packages including DP development, freeze-drying, technology transfers, scale-up, validation programs, analytical support, stability studies, regulatory, label & pack (incl. serialization) and final GMP release.
https://bioconnection.eu/
Marijke.millenaar@bioconnection.eu
Founded in 1999, PHSE is today a market leader providing GDP compliant time-critical and temperature-sensitive supply chain solutions to the pharmaceutical, biotech and life sciences industry, serving the hospital, home care and clinical research channels. It ranks internationally among the few providers specializing exclusively in the healthcare segment and in the management of worldwide shipments by air, land and sea of pharmaceuticals, biotech, clinical trials and biological samples, at any required temperature conditions. The year 2020 marks an important step in the development of PHSE’s international platform, which counts 4 acquisitions between 2021 and 2023 in UK, India, Brazil and Italy.
Akesa embraces the spirit of innovation that fuels new drug development.
As a leading clinical trial supply and patient centric solutions provider, Akesa understands the challenges sponsors face in forecasting, planning, and sourcing comparator products, combination therapies, concomitant medication and analytical samples for their clinical trial projects. Their years of experience, market knowledge, consultative service approach and supplier relationships set them apart.
Akesa offers a comprehensive sourcing service domestically, regionally, and internationally. Procuring product according to specific project requirements (single batch, long expiry, and supporting documentation) directly from manufacturers and market authorization holders ensuring GDP supply chain and supply continuity.
Akesa Access offers patient centric solutions to streamline access to medicines.
Their Trial services are designed to give their customers a complete end to-end solution for their clinical trial supply projects. They provide project management, forecasting and planning, product sourcing, labelling, storage, and distribution direct to either site or to patient.
CT Connect is Akesa’s on-demand clinical trial site sourcing solution, designed to simplify and streamline the supply of clinical trial medicines for the Sponsor, Pharmacy and Clinical Trial Site.
Connect today to learn how Akesa can support your clinical trial. www.akesagroup.com
Founded in 1982, Lighthouse Worldwide Solutions is the world’s leading supplier of real time contamination monitoring systems and airborne particle counters. The company has leveraged its superior software design, data integration ability and worldwide support offices to provide its customers with leading edge contamination monitoring solutions. These solutions have allowed Lighthouse’s customers to maintain high product yields through continuously monitoring conditions that may have an adverse effect on their products. The Lighthouse Monitoring System and Lighthouse line of airborne particle counters have become the standard for many companies, such as Amgen, Genentech, Baxter, Pfizer, Bayer, Novo Nordisk, SpaceX, Tesla, Seagate, TSMC, Samsung, Lockheed Martin, Microchip, Medtronic, 3M, Boston Scientific and many more.
Lighthouse offers the most complete line of contamination monitoring solutions available that include Airborne Particle Counters, Microbial Samplers and Liquid Particle Counters, as well as Temperature / Humidity sensors. These solutions are now found in semiconductor, pharmaceutical, data storage, biotechnology, aerospace and defense industry plants worldwide.
The Lighthouse line of award-winning particle counters is composed of a complete line of handheld, portable and remote particle counters with features such as Touch Screen Displays with zoom capability, Detailed reporting functions, Historical data review, Removable / Rechargeable Li-ion Batteries, and Alpha Numeric location labels just to name a few. Lighthouse also designs, installs and maintains some of the largest, most comprehensive contamination monitoring systems in the world and offers a complete package of calibration, service, repair, contamination control training and consultation services.
Company website:
BioPharma APAC, your go-to source for the latest insights and updates in the dynamic world of biopharmaceuticals across the Asia-Pacific region. We deliver comprehensive coverage on breakthroughs, industry trends, regulatory developments, and innovations shaping the rapidly evolving landscape. Stay informed with BioPharma APAC as we navigate the intricate intersection of biology, medicine, and business, bringing you the forefront of biotherapeutics and pharmaceutical advancements in this vibrant and crucial part of the world.
Komtur Pharmaceuticals is an international wholesaler and specialized service provider for the pharmaceutical industry. With branches and partners in every major market worldwide, we have built an unmatched global network to complement our long-standing reputation for innovative solutions, reliability in sourcing hard to find pharmaceuticals and getting medicines to patients in good time.
It is our mission to support our partners in the pharma industry at any phase of the product life-cycle to bring their products to market and make them available to patients around the world, in-line with our vision to be the world’s most trusted patient-centric partner for the pharmaceutical industry.
GTP Bioways is a customer-centric and science-driven CDMO expert in process development and GMP manufacturing of biologics, antibody-drug conjugates and nanodrugs.
With four cutting-edge facilities located in France, GTP Bioways can support biopharma companies from preclinical to commercial production of their innovative therapies.
GTP Bioways integrated services cover the whole value chain of biotherapeutics development, from R&D to GMP manufacturing, including in house cell line/strain development and drug product manufacturing. Drawing on our expertise in solving difficult client problems, we strive to offer a tailored approach, finely tuned to overcome each specific challenge.
Equilab International is the first CRO in Indonesia as well as the first CRO in South East Asia that got approval from WHO.
They have established their end-to-end services for customers from all around the globe by providing the services for clinical trial, central lab, pharmacokinetics and bioavailability studies, and dermatology studies. Equilab International has completed more than 1,000 clinical studies. At the heart of this proven track record of success is its expertise and dedicated facilities, which boost a pharma and biologics company’s clinical study with accurate and timely data that aligns with their project deadlines and required international regulations. Equilab International’s success in conducting large-scale clinical trials can also be attributed to Indonesia’s populace, which comprises over 300 ethnicities and prevalence of a wide range of diseases, allowing consistent recruitment of patients for various drug development projects, and their successful story to get Material Transfer Agreement (MTA) from Indonesian MOH.
During the pandemic, Equilab successfully managed more than 10 vaccine trials with a large number of participants (up to 9,500/study), which shows their expertise as a global clinical trial company capable of managing large studies. Besides vaccine trials, they also has extensive experiences in hormonal, nutritional, cardiovascular, endocrine, oncology, and dermatology clinical trials.
Having an accredited facility, Equilab International is also the choice for central laboratory and pharmacokinetics laboratory. The complete set of skillful operation team and acknowledged facility has made Equilab International become the leading CRO in Southeast Asia.
The global operating process solution provider Single Use Support helps biopharmaceutical manufacturers advance their fluid & cold chain management of drug substances and advanced therapies. Headquartered in Austria, the pioneering company specializes in developing process solutions for a 100% safe fluid transfer in pharmaceutical manufacturing. Its innovative product solutions includes protective shells for all single-use bags on the market and single-use manifold assemblies as well as automated platforms for fill-filtration, freeze-thaw and homogenization of substances. Single Use Support’s mission is to enable the safe, sterile, and permanently frozen transport of biologics and highly valuable advanced therapy medicinal products around the globe.
As a global leader in pharmaceutical logistics, World Courier moves medical logistics forward. We constantly work to improve supply chain efficiency and certainty of delivery. We fully understand our customers’ needs and navigate pharmaceutical logistics complexities with care. At World Courier, whether we are supporting clinical trials, delivering life-saving treatments for patients or securing complex manufacturing processes, we transport your most precious shipments with flawless execution.
Aton (Shanghai) Biotech Co., Ltd. is a rapidly growing biopharmaceutical Contract Development and Manufacturing Organization (CDMO). Aton prioritizes quality and is dedicated to empowering integrated biopharmaceutical drug development and manufacturing, enabling customers to accelerate their pipeline to market. Aton’s services cover end-to-end CDMO services from cell line construction to commercial manufacturing, including the development and production of monoclonal antibodies, fusion proteins, bispecific antibodies, ADCs (Antibody Drug Coupling Compounds), etc. Now Aton is equipped with two R&D and manufacturing sites, supported by a quality management system that meets the requirements of the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and China’s National Medical Products Administration (NMPA). In addition to the industry-leading manufacturing technology platform, Aton has established a first-in-class biopharmaceutical R&D, manufacturing, and operational management team with a high-quality talent reserve and a robust team structure. The core management team has an average of more than 15 years of senior management experience in the industry and possesses professional management expertise in R&D, clinical, manufacturing, CMC, quality, and compliance from leading multinational pharmaceutical companies.
GenScript Biotech Corporation (HK.1548) is the world’s leading technology and service provider of life science R&D and manufacture. Built upon its solid gene synthesis technology, GenScript Biotech is divided into four major platforms including the life science service and product platform, the biologics contract development and manufacturing organization (CDMO) platform, the industrial synthetic products platform, and the integrated global cell therapy platform.
Advanced Instruments is a global provider of scientific and analytical solutions for the biopharma and clinical industries
Our company’s innovations have helped organizations improve quality, achieve reliable outcomes, and increase productivity for more than 65 years.
Our focus on service, quality, and reliability has made us a leading developer and manufacturer of analytical instruments and services for the biopharmaceutical, clinical, and food & beverage industries. Our newest addition, the Artel portfolio, includes leading analytical instruments, software and services that validate, automate, and calibrate critical liquid handling processes and instrumentation. Our Solentim portfolio delivers best-in-class imaging and single-cell deposition technologies for cell line development workflows. And our OsmoTECH® and OsmoPRO® micro-osmometers support the workflows that labs worldwide rely on for the delivery of accurate and timely results.
Capricorn is a rapidly expanding life science company that produces media, buffers, and reagents. We serve customers worldwide in the areas of academic research, industrial production, and distribution. With our focus in the field of biotechnology, we particularly concentrate on customers’ cultivation of CHO, Vero, HEK, and Insect cell lines. Understanding the critical role that specialized media and reagents play in optimizing cell culture processes, we are committed to pushing the boundaries of biotechnological advancements.
Capricorn is actively seeking partnerships with small- to mid-sized enterprises that share our vision of introducing innovative products to the global market. Our organization possesses the advanced capabilities required to efficiently manufacture biotechnological products with the highest quality standards, coupled with the extensive strategic reach necessary to access international markets.
In our pursuit of excellence, Capricorn is keen to establish collaborative ventures with companies that boast expertise in media development and possess proprietary media formulations. Our intention is to forge synergistic alliances where both parties can contribute their unique strengths for beneficial outcomes.
If your organization aligns with our objectives and values, we invite you to explore the possibilities of a collaboration with Capricorn. Together, we can make a lasting impact on the biotechnology landscape.
Refeyn pioneers analytical instruments that put molecular mass measurement capabilities within easy reach for scientists. Refeyn’s unique products measure the mass of individual proteins, nucleic acids, complexes and viruses – providing vital insights for scientific discovery, R&D and therapeutics production.
Our instruments feature mass photometry technology, which uses light to quantify the mass of single particles in solution without labels. Providing intuitive data in minutes, mass photometry helps scientists solve their research questions, optimize R&D processes and focus on innovation.
Refeyn’s mission is to transform analytical workflows in the life sciences, biopharma and beyond, using the power of light.
BCI Global is a leading independent consultancy and implementation firm found in 1985, with headquarters in The Netherlands. Besides our HQ we have offices and teams in Germany (Frankfurt), UK (London), North America (Atlanta, Dallas, LA, San Francisco) and Asia (Singapore, Shanghai).
We support our clients globally in manufacturing footprint strategy, supply chain optimization, location & site selection for plants, DCs and offices and we provide implementation management services. We have a strong track record in life sciences with example clients such as e.g. J&J, Pfizer, Amgen, Biogen, Ipsen, Novo Nordisk, AstraZeneca, GSK, Takeda, Astellas, Chimerix, Amylyx, Blueprint Medicines, Exelixis, Krystal Bio, Aimmune and many others.
More information: Johan Beukema, Managing Partner, johan.beukema@bciglobal.com; Martin Gouda, Partner, martin.gouda@bciglobal.com
Our website: www.bciglobal.com
Almac Clinical Services, part of the Almac Group, currently provide services to over 600 Pharmaceutical and Biotech companies worldwide including the top 20 global pharma companies. Guided by our extensive clinical supply experience and expertise, we are recognised as one of the leading, multi-faceted, global solution providers within the niche and complex market of clinical trial supply. Utilising our best in house Supply Chain Management expertise, custom designed services and software solutions, we offer the most flexible approach to support the delivery of your global clinical trial from protocol right through to patient delivery.
https://www.almacgroup.com/
Premiere European CMO with production facilities for murine monoclonal antibodies for use in biopharmaceuticals, human diagnostics, veterinary diagnostics & food analysis. Diatec Monoclonals is an experienced and flexible partner for your antibody production outsourcing needs. Diatec Monoclonals offers a complete range of services from establishment of hybridomas and cell banking, in vitro antibody production and downstream processing of the product. Diatec Monoclonals offers excellence in service standards, technical support and product quality supported by a competitive pricing strategy.
We enable regulated organizations to move from paper-based validation to intelligent, digitized, paperless solutions.
And we do it through the ongoing development of a powerful, purpose-built software platform. In 2014, after 8 years of intensive software development, we launched the world’s most advanced validation software to help revolutionize the speed, precision, transparency and intelligence of validation in the Life Sciences sector. The solution is now used by some of the world’s leading Life Sciences companies.
Our new implementations range from a single validation process, in one location, to full deployments for multiple processes over many sites, with thousands of users; all supported by our teams in the US, Ireland and Switzerland. Our global operational headquarters and development teams are based in Ireland, and the company is listed on the TSX Exchange (TSX: KSI).
STERIS offers Customers a unique mix of innovative capital equipment products, such as sterilizers and washers, surgical tables, lights and equipment management systems and connectivity solutions such as operating room integration; consumable products such as detergents and gastrointestinal endoscopy accessories, dental instruments and other products; services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair solutions, laboratory services and off-site reprocessing.
Since 1956, we have been manufacturing positive displacement pumps and providing engineering support to a range of industries. We started in Marlow, Buckinghamshire, where the inventor Bernard Refson developed the first technically, and commercially, viable peristaltic pump for use outside the laboratory.
In 1969, we moved to our base in Falmouth, Cornwall. We have since expanded geographically to serve over 60 markets worldwide. We are formed of 10 leading brands, each a specialist in niche fluid transfer technologies. In 1990 we became part of Spirax Sarco Engineering plc, a FTSE100 company. As part of SSE, our shared purpose is to create sustainable value for all our stakeholders as we engineer a more efficient, safer and sustainable world.
We are problem solvers. Our people around the world are specialists in the work they do, and the company is structured to empower and support individuals. This extends to the products and services we provide our customers who have come to know us for our quality.
BionPak is ISO 13485:2016 Certified site.
We provides Packaging Solution to the bio and pharmaceutical areas to enable execution of stable sterilization process.Products are manufactured with the best quality in clean room through exhaustive quality control by using sterilized packaging product with the use of DuPont™ Tyvek®.
We are sourcing products with verified manufacturing environment and quality, and supplying them to our clients in the areas of pharmaceutical & bio with the utmost priority on the customer value.
Zuellig Pharma is one of the largest healthcare services groups in Asia and our purpose is to make healthcare more accessible. We provide world-class clinical trials logistics, distribution, digital and commercial services to support the growing healthcare needs in this region. The company has grown to become an over US$15 billion business covering 13 markets with over 13,000 employees, serving over 350,000 medical facilities and working with over 500 clients, including the top 20 pharmaceutical companies in the world.
Our Clinical Reach team partners with global, regional and local clients, providing end-to-end clinical supply chain solutions and have supported over 5,500 clinical trials through our regional and local depots as well as comparator and ancillary sourcing services.
Zuellig Pharma is one of the largest healthcare services groups in Asia and our purpose is to make healthcare more accessible. We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region. The company was started a hundred years ago and has grown to become a US$15 billion business covering 13 markets with over 13,000 employees. Our people serve over 350,000 medical facilities and work with over 1,000 clients, including the top 10 pharmaceutical companies in the world.
More recently, we launched our Zuellig Health Solutions Innovation Centre to develop new services and address some pressing healthcare needs in Asia. Since then, our teams have been focused on creating data, digital and disease management solutions, supporting patients with chronic conditions and helping payors manage healthcare costs.
Zeta Pharma is fast-growing Egyptian company that was established in 2010 to represent an added value in the pharmaceutical industry.
Zeta Pharma had a well selected and unique product portfolio in all therapeutic areas.
Zeta Pharma Has started its marketing activities in 2015 on the products for Hepatitis C Virus (Sofocivir, Zetaciver & Sofocivir Plus).
In collaboration with the Egyptian Ministry of Health and Egyptian Liver Research Institute, ZETA PHARMA® has managed to treat more than 60,000 patients with healing rates 95 % similar to those of the global rate.
Yourway is the only truly integrated premium courier and clinical packager, offering — along with our comprehensive transport capabilities — primary and secondary pharmaceutical packaging services, warehousing, and distribution support, including temperature-controlled solutions, unused product return services, including product destruction, and assistance with logistics project management. The latter services include sourcing of comparator drugs and other supplies, establishing optimal delivery strategies across global trials, documentation support and the provision of regulatory advice regarding country-specific requirements. Our team of specialists is highly experienced in supporting clients’ needs for the execution of phase I, II, III and IV clinical trials. With all logistics needs for clinical trials easily obtained in one place, outsourcing to, or managing relationships with multiple organizations is no longer necessary.
Visit www.yourway.com.
Yokogawa and Pharmaceutical companies continue to co-innovate to create pharmaceutical manufacturing solutions that deliver safe and reliable medicines. We apply digital transformation(DX) and manufacturing advances that lead to compliance with regulatory requirements, embed quality in the process, and speed time to market.
More than just automation, we envision an autonomous SMART cGMP Factory for our customers, where our Pharma 4.0 solutions integrates all aspects of biomanufacturing from R&D to factory floor, to shop floor to cost management to enable you to Do It Right First Time.
WuXi Vaccines (https://www.wuxibiologics.
WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics from concept to commercialization for the benefit of patients worldwide.
With over 10,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As of June 30, 2022, WuXi Biologics is supporting 534 integrated client projects, including 14 in commercial manufacturing.
WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of our ethos and business strategy, and we aim to become an ESG leader in the biologics CRDMO sector. Our facilities use next-generation biomanufacturing technologies and clean energy sources. We have also established an ESG committee led by our CEO to steer the comprehensive ESG strategy and its implementation, enhancing our commitment to sustainability.
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of lifesaving and life-enhancing medicines for patients. With almost 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 40 billion components and devices each year.
Headquartered in Exton, Pennsylvania, and in business for nearly a century, West in its fiscal year 2020 generated over $2.147 billion in annual revenue. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor’s 500 index. For more information, visit www.westpharma.com.
Waters Corporation unlocks the potential of science through analytical measurement technology, deep scientific expertise, and reliable insights to enhance human health and well-being.
As a global provider of analytical technology, Waters makes scientific ambitions a reality through the application of liquid chromatography, mass spectrometry and thermal analysis instruments, consumables, and informatics as well as industry-leading scientific expertise.
For over 60 years, the company has distributed its products globally to a variety of industries, including pharmaceuticals, chemicals, food, environmental, forensic toxicology, biomedical research, and clinical diagnostics. With more than 7,400 employees worldwide, Waters operates in 35 countries, including 14 manufacturing facilities, with products available in more than 100 countries.
At VFV, our mission is to facilitate the Advancement of Humanity by supporting Australian businesses and entrepreneurs who dedicate their lives to scientific discovery and product developments.
VFV is Australia’s trusted supplier of single use products for Biopharmaceutical manufacturers. With a National Sales presence and large inventory held in our Melbourne warehouse, we ensure the world’s most innovative Single Use products are readily available to large and small manufacturers lucky enough to be operating in Australia. We operate under an ISO9001 accreditation, and our production team manufacturer single use assemblies in our ISO Class 7 Cleanroom facility where we offer the most rapid turnaround times in the industry.
VectorBuilder: Revolutionize Gene Delivery from Research to Therapy
VectorBuilder is specialising in advanced genetic engineering solutions for research and medicine.
As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside.
We offer a range of products and services including vector design and cloning, virus packaging (Lentivirus, Adenovirus, AAV, MMLV, MSCV, Baculovirus, VSV and HSV), library construction, stable cell line generation, IVT mRNA synthesis and GMP manufacturing of clinical-grade plasmids, mRNAs and viruses.
ValGenesis automates and develops intelligent engineering solutions for Life Sciences companies by optimizing the entire lifecycle of its products and processes to achieve operational excellence. Our state-of-the-art digital solutions fit into the culture, user-requirement specifications, regulatory demands, and the IT ecosystem of the pharmaceutical industry to assure our clients that our solutions are ready for validation, risk management, continuous process verification, and much more. We have innovative IT products and solutions that allow the Pharmaceutical Industry to update from Paper-based processes to leverage Pharma 4.0 and digitalization efforts.
Link to your website
UPS Healthcare delivers unparalleled healthcare logistics expertise to its customers around the world. UPS Healthcare has 11+ million square feet of cGMP and GDP-compliant healthcare distribution space globally. Services include inventory management, cold chain packaging and shipping, storage and fulfillment of medical devices, and lab and clinical trial logistics. UPS Healthcare’s global infrastructure, its UPS® Premier visibility service, its track and trace technology, and its global quality system are well-suited to meet today’s complex logistics demands for the pharmaceutical, medical device, and laboratory diagnostic industries.
Website: healthcare.ups.com
Unither Pharmaceuticals is a 30-year-old French CDMO and world-leader in sterile unit doses using Blow-Fill-Seal (BFS) technology to produce eye drops, saline solutions, and asthma medications. It has a capacity of 5 billion BFS doses with products sold in over 100 countries. Unither recently introduced Euroject®: an innovative BFS-based device for single dose injection of therapeutics, contributing to greater equity in access to vaccines and ensuring safe vaccine administration, while being user-friendly and cost-effective. It employs more than 2000 people in 8 manufacturing plants and R&D center in France, Brazil, China, and the US. Its turnover in 2022 was €371 million.
For over 200 years, USP has worked to build trust where it matters most: in the world’s medicines, dietary supplements and foods. Through our rigorous science and the public quality standards we set, USP helps protect patient safety and improve the health of people around the world. USP is an independent, scientific nonprofit organization focused on building trust in the supply of safe, quality medicines. We are working to strengthen the global supply chain so that the medicines people rely on for health are available when needed and work as expected.
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Turkish Cargo is the fastest growing and developing air cargo brand of the world, with a global network on all continents. The air cargo brand provides air freight services to more than 340 international destinations, with 98 direct cargo flights. Raising its bar by connecting the wide network with the geographical advantage of Turkey, Turkish Cargo now incorporates all of its air cargo transportation operations in SMARTIST, the Mega Cargo Facility. Turkish Cargo, aims to become one of the top 3 air cargo brands in 2025.
Founded in 2000, Truking Technology Limited has become one of the major pharmaceutical equipment suppliers in the world. The
company specializes in pharmaceutical equipment and the corresponding integrated solutions, and takes the initiative to push forward
the R&D of smart pharmaceutical factory.
It is a listed A-share company with multiple wholly-owned or controlling subsidiaries, namely Germany based Romaco Group, Truking
Watertown, Sichuan Pharmaceutical Degisn Institute, Truking Feiyun, Truking Ingenuity Biotechnology, Truking Wachine, Truking
Intelligent Robot, etc.
The company has over 6500 employees around the global, a total asset of RMB 6.9 billion and annual output value of RMB 8
billion.TRUKING has two operation headquarters respectively in Changsha, China and Germany; 4 big research institutes, namely
Changsha Central Technology Research Institute, Europe Technology Research Institute, Sichuan Pharmaceutical Design Institute, and
Suzhou Technology Research Institute.
Truking has established National Enterprise Technology Center, National Innovation Center, Post-Doctoral Research Center,
Academician Expert Workstation and many more technology and innovation platforms.
To better respond to the needs of global customers,Truking has been setting up sales and service centers in many countries including
India, Italy, Greece, Russia, Uzbekistan, Turkey, Egypt, Bangladesh, Korea, Vietnam, Thailand, etc.
By August 31, 2022, Truking has submitted 4342 patent applications, and been granted with 2684 patents.
Beyond China, Truking has applied for 40PCT international patents, and been granted with 20 patents in USA, Russia, India, Korea,
Germany, Indonesia, and many more European countries. Truking also took the lead in formulating 17 national industrial product
technical standards. Our products have been exported to more than 40 counties and regions to Asia, Europe, and South America.
Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA)
TRPMA on behalf of Taiwanese R&D-based biopharmaceutical and regenerative medicine industry is actively promoting life science R&D, capital investment, business alliances and international collaborations. Our mission is to build up a globally competitive value chain of the innovative life science industry to boost Taiwan’s economy and to enhance the health and welfare of global people.
TrakCel is the first provider of integrated cellular orchestration solutions for the precise management, control and tracking of cell and gene therapy products. With the largest number of live clinical trial and commercial therapy deployments and supporting the broadest number of therapy classes in industry, TrakCel has built a deep understanding of the unique challenges faced by advanced therapy developers globally.
We provide cell and gene therapy software solutions that offer visibility, insight and scalability to streamline the value chain and the delivery of therapies to patients.
Website link
Tower Cold Chain is the essential link in the stability of the cold chain. Its robust, reliable and reusable innovative containers provide proven physical and temperature protection for pharmaceutical and life science products, preventing shipments from being spoiled or delayed, and ensuring the delivery of temperature-sensitive products on time and budget.
Since 2007, we provide temperature-controlled solutions to the global pharmaceutical, life-science and biotech industries.
We are trusted by global pharmaceutical, logistics and airline companies and our experienced team, supported by a centralized quality-management system, reinforces customer confidence that our shipping facilities will meet requirements throughout the supply chain and safeguard your products.
Our patented design technology ensures our solutions meet the pharmaceutical industry performance standard, providing a minimum of 120 hours temperature compliance in any environment, anywhere in the world.
We understand what our customers and their market needs and can deliver customer-focused innovation in temperature-controlled protection to create value within their supply chain. By collaborating with our customers, we can transport products safely, whenever and wherever they are needed.
Tofflon Science and Technology Group Co. Ltd. was established in 1993 and is a one-stop solution provider for bio/pharmaceutical industry. Besides being a comprehensive pharmaceutical equipment supplier, Tofflon also provides process support, core equipment, integrated systems, pharma engineering (Modular construction & Site build construction) and consumables such as media, resin and single use systems for the pharma and biotech industry around the world.
Since founded, Tofflon has supplied and supported more than 12,000 sets of equipment and systems for 3,000 pharmaceutical companies across over 50 countries and regions in the world which have been widely applied in the fields of R&D, liquid and lyo injectables, chemical API, bioengineering and pharma packaging. Tofflon has also been approved with all the international regulatory certifications like German TUV ISO9001, ISO14001, OHSAS 18001, CE, UL, ASME, PED, etc.
Today, Tofflon Science and Technology Group Co. Ltd has over 5500 employees around the globe with a total asset of over 2 billion USD. The company currently has several R&D centres around the world (China, Italy and Germany) and is expanding further. Through our Technological Innovation and Development Concept: Automation, Intelligence, Modularization, Continuous Processing and System Integration, we create values for the industry and our partners: cGMP compliance, High Efficiency, Automation, Simple Interface, Cost Effective, Easy Validation, Integrated Service, and Faster Time to Market.
Thermo Fisher Scientific provides industry-leading pharma services solutions for drug development, clinical trial logistics, and commercial manufacturing to customers through our Patheon brand. With more than 60 locations around the world, we provide integrated, end-to-end capabilities across all phases of development, including API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics services, and commercial manufacturing, and packaging.
We offer integrated drug development and clinical services tailored to fit your drug development journey through our Patheon™ Quick to Care™ program. Our Patheon™ Quick to Clinic™ programs for large and small molecules help you balance speed and risk during early development so you can file your Investigational New Drug Application (IND) quickly and successfully.
Thermo Fisher Scientific, Pharma Services (Patheon)
Thermo Fisher Scientific provides industry-leading pharma services solutions for drug development, clinical trial logistics and commercial manufacturing to customers through our Patheon brand. With more than 55 locations around the world, we provide integrated, end-to-end capabilities across all phases of development, including API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics services and commercial manufacturing and packaging. We give pharma and biotech companies of all sizes instant access to a global network of facilities and technical experts across the Americas, Europe, Asia and Australia. Our global leadership is built on a reputation for scientific and technical excellence. We offer integrated drug development and clinical services tailored to fit your drug development journey through our Quick to CareTM program. As a leading pharma services provider, we deliver unrivaled quality, reliability and compliance. Together with our customers, we’re rapidly turning pharmaceutical possibilities into realities.
In APAC, currently we have biologics manufacturing site based in Brisbane, Australia.
In 2022, we will expand our presence in APAC and launch Biologics and Sterile fill finish site in Hangzhou, China and Sterile fill finish site in Singapore.
For more information, please visit our booth.
Terumo Pharmaceutical Solutions develops patient-oriented parenteral delivery solutions for therapeutic performance and safety Globally trusted for quality and precision, Terumo Pharmaceutical Solutions offers pharmaceutical and medical device manufacturers around the world comprehensive product design and development services, for primary container, injection, infusion therapy devices, and contract development and manufacturing services (CDMO).
We have decades of experience collaborating with pharmaceutical companies from the earliest phases of drug development to product commercialization to optimize critical aspects of parenteral
drug delivery. Innovation and creativity are central to our value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for
all parenteral applications. We provide sterile injectable contract development and manufacturing (CDMO) services from initial combination device design and formulation development to commercial manufacturing.
supporting better patient outcomes around the world.
We listen. We question. We deliver.
Terumo Pharmaceutical Solutions develops patient-oriented parenteral delivery solutions for therapeutic performance and safety Globally trusted for quality and precision, Terumo Pharmaceutical Solutions offers pharmaceutical and medical device manufacturers around the world comprehensive product design and development services, for primary container, injection, infusion therapy devices, and contract development and manufacturing services (CDMO).
We have decades of experience collaborating with pharmaceutical companies from the earliest phases of drug development to product commercialization to optimize critical aspects of parenteral
drug delivery. Innovation and creativity are central to our value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for
all parenteral applications. We provide sterile injectable contract development and manufacturing (CDMO) services from initial combination device design and formulation development to commercial manufacturing.
supporting better patient outcomes around the world.
We listen. We question. We deliver.
Since its founding in 1989, the Taiwan Bio Industry Organization (Taiwan BIO) has been promoting the interests of its members from industry, the government and academia as well as promoting the development of the biomedical industries and their contribution to Taiwan’s economy and people. The more than 100 organizations and 3,000 individuals that make up Taiwan BIO membership represent the entire life sciences industry spectrum, including from the biotechnology, pharmaceutical, diagnostics, medical devices and materials, agricultural biotechnology, and nutraceuticals sectors.
Stelis Biopharma Limited (Stelis) is a fully integrated pure-play biologics Contract Development and Manufacturing Organization (CDMO), offering the complete spectrum of services, from cell line technology transfer to clinical and commercial manufacturing with capabilities to convert drug substance into stable formulations and fill and finish formats. With proven technical expertise in microbial, mammalian, viral vectors, and various other technology platforms with world-class cGMP manufacturing facilities that offer high-quality services for your global programs.
Stelis has three state-of-the-art facilities, with ~85,000 sqm of area house process development laboratories, scale-up, and manufacturing areas for mammalian, microbial and other modalities. The company’s highly automated facilities provide global services for products based on Monoclonal antibodies, Fusion proteins, Conjugation factors, Vaccines, Cell-free protein expression platforms, DNA adjuvants/plasmids, RNA products, Cell and gene therapy, and all other types of biologics, biosimilars and vaccines. It’s agility in building capacities, increasing accuracy, efficiency and speed at every stage of process development and manufacturing processes is unparalleled.
Stelis, over the years, has built a robust CDMO platform. Offers large drug substance capacities of over 48,000L across various modalities and drug product capacities exceeding 400 million units per annum. The company has the capabilities to deliver your projects from clinical to commercialization with best-in-class facilities capable of delivering any scale of production volumes with agility to expand capacities at industry-leading speed. With 48,000L of drug substance capacities across multiple modalities, Stelis is one of the largest CDMOs in the Asia-Pacific (APAC) region.
The company’s experienced quality and regulatory personnel help meet the highest global quality standards, ensure compliance and guide it’s clients through the regulatory approval. The large-scale commercial use facilities were designed with consultation from international regulatory agencies, including the USFDA, and a holistic and systematic approach to building and sustaining the Stelis Quality Culture.
For more information, visit www.stelis.com.
Sparta Systems, a Honeywell Company, brings leading-edge quality management solutions to regulated industries. With nearly three decades of experience, Sparta provides enterprise and cloud-based QMS software solutions that help companies go to market faster while minimizing product risks and ensuring compliance. Sparta is an innovator in its field and is driving smart quality with first-of-its-kind AI-enabled quality solutions. By applying the latest digital technologies, our products simplify the process of quality management and guide customers toward proactive quality.
The combination of Sparta Systems and Honeywell brings together Sparta’s quality management leadership with over 100 years of industrial and software expertise from Honeywell. Together, Sparta and Honeywell will shape the future of digital quality and operational excellence for the life sciences industry.
Our Solutions: TrackWise, TrackWise Digital and QualityWise.ai
Website: https://www.spartasystems.com/
SkyCell is a purpose-led technology company transforming the pharmaceutical supply chain through a combination of proprietary software, hardware, and big data. It is the leading manufacturer of temperature-controlled door-to-door container solutions that allow pharma companies to optimise their supply chain by reducing, and even predicting, the risks associated with delivering sensitive drugs by air. Its SaaS solution, SkyCell SECURE, enables pharma companies to have real-time, end-to-end oversight of every shipment around the world, and its automated approval capability reduces quality approval time from an average of 14 days to just hours, getting life-changing drugs to consumers faster.
Designed with sustainability as a core principle, SkyCell’s technologies protect healthcare systems by reducing in-transit failure rate to a market-leading low of less than 0.1% temperature excursions and reduce the CO2 impact of each shipment by almost half the average rate. SkyCell is operationally climate-neutral today and has committed to the goal of end-to-end climate neutrality by 2040. SkyCell’s sustainability targets are science led and aligned to both the Paris Agreement and UN sustainable development goals.
Founded in 1986, Signet is a pioneer in the excipients business in India.
Since its inception, Signet has combined technical expertise with commercial support to provide its clients accurate information and exceptional product value. With 105 qualified and well-trained members, the Signet team has an excellent understanding of the intricacies of the market and has strong relationships with key partners to take the company forward. Today, the entire team’s passion and commitment has made Signet an employer of choice for young talent.
At Signet, the numbers speak for themselves. Since 2011, the company has grown consistently at 13.37% CAGR to go from INR 414 crore to INR 1453 crore in 2020 (approximately USD 198 million)
Today, with over 850 customers across 1250 manufacturing locations in India; Signet’s total volume of business has crossed 25,000 metric tonnes per annum. Having consistently kept ahead of the industry’s growth rate and with an array of over 400 quality products, Signet has become the ‘First Recall’ name for excipients in the pharmaceutical Industries of India & Indian Subcontinent.
Together, we impact life and health with science. We offer one of the broadest portfolios in the industry for scientists, best-in-class products for pharmaceutical development and manufacturing, and a fully integrated service organization to support CDMO and contract testing across traditional and novel modalities. Our vision is a world where our innovative products, services, and digital offerings help create solutions for people globally and a sustainable future for generations to come.
Shimadzu Corporation, Japan founded in 1875 and having a history of more than 145 years, is one of the leading Manufacturers & suppliers of Analytical, scientific & testing instruments such as Chromatography, Mass-Spectrometry, Spectroscopy, Testing instruments, Environmental monitoring instruments. Shimadzu Analytical (India) Pvt Ltd, a wholly owned subsidiary of Shimadzu Corporation, Japan, offers an extensive range of instruments, value added services & customer support.
Shimadzu has been serving the Indian scientific community since many decades now, through its well-established network of distributors namely Toshvin Analytical, Spinco Biotech, Swan Environmental, Amkette Analytics & Perfomax Analytical for various product ranges.
The Customer Support Centres (CSC) in India were established in Mumbai (2006) & New Delhi (2008) to reaffirm the commitment towards our valued customers. Our state-of-art facility showcases a wide range of analytical instruments with the key objective of providing application support & continuous technical training for analytical scientists to offer the best possible solutions to face the challenges faced by the analysts.
With over 35 years’ experience as a global contract service organization, SGS provides integrated (bio)pharmaceutical development and testing solutions including clinical research, pharmaceutical development, biologics characterization, biosafety, and quality control testing for small and large molecules, raw materials, containers and finished products.
SGS provides a comprehensive range of biosafety services such as: virology, cell and molecular biology, microbiology and TEM. Health Authorities (US FDA and the EMA), require companies to undergo safety testing demonstrating that cell banks, viral banks, raw materials, bulk harvests, and batches of clinical drug are free of bacteria, fungi, mycoplasma, viruses and other potential contaminants. SGS ensures product safety in satisfying these regulatory requirements.
Website: https://www.sgs.com/en/our-
At SCIEX, our mission is to deliver solutions for the precision detection and quantification of molecules, empowering our customers to protect and advance the wellness and safety of all. SCIEX has led the field of mass spectrometry for 50 years. SCIEX mass spec systems—as well as other life science products including capillary electrophoresis instruments, front-end HPLC MS products, software, and complete integrated solutions are used extensively in labs focused on environmental testing, food and beverage testing, pharma and biopharma discovery and development, forensics screening, clinical diagnostics, and life science research.
Sartorius is a German-based company that specializes in providing pharmaceutical and laboratory equipment solutions. With a focus on Bioprocess Solutions and Lab Products & Services, Sartorius Life Science Research portfolio delivers innovative products and services to support researchers in academia, biotechnology, and the pharmaceutical industry. Our portfolio includes solutions for cell analysis, liquid handling, weighing applications, sample preparation, laboratory water, and related services. We are committed to helping researchers achieve their goals for reliability, reproducibility, and speed-to-result. As one of the few companies capable of meeting the complex needs of customers in this market, our focus is on Pharma, Academia and Biopharma market, driving innovation, and simplifying workflows to help our customers get to market faster and cheaper with solutions, services & support.
SaniSure is a global leader in the design and manufacturing of single-use systems and components for drug and vaccine manufacturing and other biotech and pharmaceutical applications. With the consolidation of several strategic acquisitions under one integrated roof, the combined resources, competencies and ability to create value for customers is unmatched in the industry. SaniSure’s core manufacturing capabilities include cleanroom assembly, fabrication, injection molding, injection stretch blow molding, tubing extrusion, filling-needle manufacturing, and many additional proprietary technologies.
SaniSure offers a wide range of single-use technology systems and components including Mixed4Sure™ mixing solutions, complex sterile assemblies, PharmaTainer™ bottles and carboys, Cap2V8® bottle closures, Pharma-Clear® Silicone Tubing, Cellgyn® TPE tubing, Pharma- Line™ tubing, aSURE® fittings, and many more.
SaniSure has a growing global footprint of five engineering and manufacturing sites worldwide to provide customers with an unrivaled level of innovation, quality, and vertical integration/supply-chain security.
Royale International are logistics specialists in handling sensitive, temperature-controlled products and deliver with extreme care and precision, all across the globe. The Life Sciences Division manages a wide range of temperature-controlled shipments for various sectors such as; pharmaceuticals, healthcare, biotech, medical devices, cell & gene therapy, clinical trials, and R&D. Royale International provides premium & customized logistics solutions via On-Board Couriers & Express freight and provides quality packaging solutions so that products are safely transported to its destination. All procedures are Customs Authority, Good Distribution Practice (GDP) and International Air Transport Association (IATA) compliant, ensuring shipments safely arrive at the right place, at the right time.
Route Biosciences is a 2 years 10 months old Partnership Firm incorporated on 17-Dec-2020, having its registered office located at 1748, E Ward, 5Th Lane, Rajarampuri, Kolhapur, Maharashtra.
The major activity of Route Biosciences is Manufacturing, Sub-classified into Manufacture of computer electronic and optical products and is primarily engaged in the Manufacture of laboratory analytical instruments and miscellaneous laboratory apparatus for measuring and testing such as scales balances incubators etc .
Route Biosciences is classified as Micro enterprise in the financial year 2021-22. It has its unit situated at Kolhapur, Maharashtra.
Roquette is a family-owned global leader in plant-based ingredients, a pioneer of plant proteins and a leading provider of pharmaceutical excipients. Founded in 1933, the company currently operates in more than 100 countries.
Life and nature have been our sources of inspiration for decades. All our raw materials are of natural origin. From them, we offer pharmaceutical solutions that play a key role in medical treatments. We truly unlock the potential of nature to improve, cure and save lives.
Discover the Pharma Virtual Lab by Roquette
Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and, most importantly, our patients remains as strong as it was on the first day of our journey.
Retrogenix, a Charles River Company provides a fast, accurate, and effective solution for primary receptor identification and specificity screening of antibodies, protein ligands, CAR T cells, and other biotherapeutics. Biologically relevant targets are identified by screening for interactions against the most comprehensive set of the plasma membrane and tethered secreted proteins that are expressed in
human cells. This informs lead selection, assists with safety assessment, and has generated data that has been used in patent applications and NDA submissions to both the US FDA and EMA.
For more details of our technology see our website animation at: www.retrogenix.com/the-technology/
Quality Executive Partners (QxP) is a global premier consulting and training firm to the pharma, biotech, and life sciences industries. QxP’s team of deeply skilled experts provide innovative and pragmatic solutions which address development, commercialization and business needs simultaneously. Our success is defined by the transfer of knowledge to our clients, enabling them to develop and commercialize quality products sustainably. QxP is the creator of the Virtuosi platform for pharmaceutical workforce education, covering aseptic processing, quality control microbiology, and cell and gene therapy manufacturing. Based on a “learn and do” methodology, Virtuosi features more than 50 on-demand e-learning video courses, and 25 virtual reality activities. Virtuosi is available in five languages.
For 43 years, QuickSTAT has been providing the leading pharma and biotech companies 24/7/365 global life science logistics solutions from R&D, clinical trials through to commercialization.
Our logistics experts provide time-and temperature-sensitive transport of clinical research samples, cell and gene therapies, investigational drugs, clinical trial supplies and vaccines, to bring new drugs to market. Strict chain of custody, chain of identity and GDP protocols ensure product integrity and patient safety for all clinical and commercial personalized medicines QuickSTAT transports. Consultation and procurement of proper packaging—from controlled room temperature to cryofrozen. Next-gen IT logistics software provided for managing your clinical supply chain with real-time temperature and tracking technology.
Website: www.quickstat.com
For over 40 years, QuickSTAT has been providing the leading pharma and biotech companies 24/7/365 global life science logistics solutions from R&D, clinical trials through to commercialization.
Our logistics experts provide time-and temperature-sensitive transport of clinical research samples, cell and gene therapies, investigational drugs, clinical trial supplies and vaccines, to bring new drugs to market. Strict chain of custody, chain of identity and GDP protocols ensure product integrity and patient safety for all clinical and commercial personalized medicines QuickSTAT transports. Consultation and procurement of proper packaging—from controlled room temperature to cryofrozen. Next gen IT logistics software provided for managing your clinical supply chain.
Website: www.quickstat.aero
QIAGEN is the leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. QIAGEN sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective molecular testing workflows. QIAGEN provides these workflows to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). Further information can be found at http://www.qiagen.com.
Proteintech Group founded by scientist since 2001, the company recognises the tireless efforts and sacrifices made by researchers to advance scientific discovery. The company headquarters in Chicago, IL, aims to match its’ customers’ dedication to research by providing high quality, reliable reagents that contribute to reproducible results. Today Proteintech is the largest original manufacturer of antibodies, and manufactures recombinant proteins in its GMP facility in Chicago, IL.
Polyplus is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services. Custom plasmid vector design was integrated into the offer in 2022 as a first measure to expanding the products and services portfolio to help customers (or the industry) optimize process economics while meeting strict scientific and regulatory standards. Headquartered in Europe, the Polyplus team continues to grow globally with operations in the United States and Asia. Learn more at www.polyplus-transfection.com.
Pneumatic Scale Angelus is a global supplier of packaging machinery for wet and dry filling, capping, can seaming, labeling, and centrifugation applications. Since 1895, our solutions have set the standard for filling and closing solutions in the Food, Beverage, Dairy, Pharmaceutical, and Household and Personal Care industries, and these solutions are fully supported by our global Service and Aftermarket network. In fact, every machine we’ve manufactured since our inception is still supported by the experts on our Field Service team.
“PharmNXTBiotech is a young Biotech Start-up based in Mumbai, it was established in the year 2017 with the idea of creating end-to-end bioprocess solutions and providing niche technologies to help reduce manufacturing costs for critical lifesaving drugs.
We recently inaugurated PharmNXTEkuse our brand new state-of-the-art single manufacturing facility based in Pune, which houses end-to-end solutions for the biopharma, vaccines manufacturing and containment solutions.
With the vision of “Make in India for the World,” we are ready to showcase our Xelta range of Single Use 2D, 3D bags and NXTmix Levitating mixing solutions along with our hardware technologies for downstream processing.
For containment solutions, we have our Make in India products: Flexible Isolators, Rigid Isolators as well as Powder Transfer Bags to handle potent molecules.”
Pharmalab International is a global trading and marketing company that specializes in natural health products. We are actively engaged in developing new natural products, cultivating the latest botanical ingredients and collaborating on joint product development projects. Utilizing our world-wide network in more than 30 countries, including many research institutes and universities, Pharmalab International strives everyday to build long-lasting partnerships with both existing and new customers who are focused on providing consumers around the world with the very best in natural health products.
SKAN is a Swiss company and a global market and technological leader for isolators and decontamination processes for the aseptic production of biopharmaceutical substances. SKAN’s core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products.
Pharmalab has allied with SKAN to provide the technological advantages of isolator technology to the Indian pharma and biotech industry. Our focus is to offer the complete solution from basic design (DQ) via construction to complete qualification (PQ) of this state-of-the-art technology to all our customers in the Indian region.
Website: www.skan.com www.pharmalab.com
Counterfeit medicinal products are a threat to the health and safety of patients around the world. They range from drugs with no active ingredients to those with dangerous impurities. They can be copies of branded drugs, generic drugs or over-the-counter drugs.
Counterfeiting groups thrive in countries where the anti-counterfeiting laws are weak, the drug regulatory agencies are underfunded and under staffed, and legal sanctions are ineffective.
In assessing these illegal operations, it became clear that the counterfeiters often copied pharmaceutical products of many manufacturers and there was a need to improve information sharing.
Meeting the Challenge
In 2002, the Security Directors from fourteen major pharmaceutical companies established the Institute in Washington, D.C. Working with its members, PSI developed improved systems to identify the extent of the problem and to assist in coordinating international inquiries.
Today, PSI membership includes thirty-seven pharmaceutical manufacturers from many nations. The Institute established representational offices with staff in Miami, Florida; Singapore; and Stockholm, Sweden.
Express Healthcare, first published as Express Healthcare Management in January 2000, has grown to become the No.1 Business News Magazine for the healthcare industry. The editorial contents include: news, views, analysis and interviews, under main segments: Market, Strategy, Knowledge, Life, Radiology, Hospital Infra, IT@Healthcare. Besides this, we bring out a quarterly publication, called In Imaging for the radiology and imaging segment.
Pfanstiehl is the market leader of high purity, low endotoxin, low metal excipients for biologics, biosimilars, vaccines, cell culture media and injectable (liquid and lyophilized) formulations and supplies its products to nearly all leading global biopharmaceutical companies.
Pfanstiehl was founded in 1919 and currently celebrating its 103rd anniversary year in 2022. Pfanstiehl is headquartered at Waukegan, IL, USA and has diverse global technical support team across the globe in USA, Europe & APAC.
Pfanstiehl has manufactured parenteral grade excipients for more than 50 years, and Pfanstiehl’s high purity, low endotoxin and low metal excipient products are known as “best in class” due to their high characterization, performance, consistency, and quality attributes.
Pfanstiehl’s excipients are critical components in the majority of the global blockbuster biopharmaceutical drugs and vaccines including majority of the Covid -19 vaccines that were administered globally.
For more information about Pfanstiehl Inc, and their products and solutions, please contact us at cs@pfanstiehl.com or visit www.Pfanstiehl.com
PerkinElmer is a leading, global provider of end-to-end solutions that help scientists,
PerkinElmer is a leading, global provider of end-to-end solutions that help scientists, researchers and clinicians better diagnose disease, discover new and more personalized drugs, monitor the safety and quality of our food, and drive environmental and applied analysis excellence. With an 85-year legacy of advancing science and a mission of innovating for a healthier world, our dedicated team of more than 16,000 collaborates closely with commercial, government, academic and healthcare customers to deliver reagents, assays, instruments, automation, informatics and strategic services that accelerate workflows, deliver actionable insights and support improved decision making. We are also deeply committed to good corporate citizenship through our dynamic ESG and sustainability programs. The Company reported revenues of approximately $5.0 billion in 2021, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available at www.perkinelmer.com. Follow PerkinElmer on LinkedIn, Twitter, Facebook, Instagram, and YouTube.e.
Peli BioThermal is the first cold chain packaging solutions provider to make available a broad and comprehensive portfolio of patented and award-winning single-use and reusable thermal protection packaging solutions for the safe transport of pharmaceuticals, clinical trials, diagnostics, tissue, vaccines and blood supplies for the life science industry.
Collaboration with our clients is the first step to ensure we provide a solution that is built around the unique and very specific needs of your temperature-sensitive payloads. Our global services network provides consultation, support, engineering and deployment for your cold chain distribution challenges wherever they exist.
Peli BioThermal designs products to ensure our customers valuable payloads are kept in perfect condition, irrespective of external temperatures and conditions. They are designed to be strong and robust, to survive the rigors of international transport. With environmental issues in mind, we ensure that our design team specify the correct materials and consider ‘end of life’ recycling for all of our ranges, whether they are single use or reusable packaging systems.
We are a global, integrated CDMO, your bridge between life-changing therapies and patients.
Our people’s priority and focus are on providing an industry-leading customer experience. Our quality framework incorporates expertise and innovation to ensure regulatory compliance and complete peace of mind.
At PathoQuest, we understand that you need to develop your innovative biologics safely and timely in a complex testing environment. PathoQuest provides a pioneering next generation sequencing (NGS) approach to biologics characterization and release testing for global biopharmaceutical and emerging biologics companies.
With a proven track record in the provision of regulated contract research services, PathoQuest offers a team of 50 genomic experts based in France and the U.S. Our expert CRO team are readily available to support with rapid and robust quality controlled (QC) testing at GMP and non-GMP level.
Let’s work together to transform the future of biologic therapies and treatments to transform patient lives.
Patheon is a service brand within Thermo Fisher Scientific’s brand portfolio. Contract development and manufacturing organization (CDMO) services offered under the Patheon brand include small molecule API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics and commercial manufacturing and packaging. In 2017, Patheon was acquired by Thermo Fisher Scientific to form its Pharma Services business.
Pall Corporation
Pall Corporation provides critical filtration, separation, and purification solutions to meet the demanding needs of a broad spectrum of life sciences and industrial customers around the globe. Across 80 locations and 10,000 people worldwide, we are unified by a singular drive: to solve our customers’ biggest fluid management challenges. And in doing so advance health, safety, and environmentally responsible technologies. Together, our Life Sciences and Industrial teams serve a diverse range of customers including biotechnology, pharmaceutical, medical, food and beverage, laboratory, microelectronics, aerospace, fuels, petrochemical, chemical, automotive and power generation industries. Our industry-leading technologies and solutions are at work in countless applications, protecting critical operating assets, improving product quality, safeguarding the health, and minimizing emissions and waste
For more info, please check: https://www.pall.com/en/biotech.html
Across 80 Pall locations and 10,000 people worldwide, we are unified by a singular drive: to take on our customers’ biggest challenges. To solve the critical problems that stand in the way of advancing health, safety and the environment. Where others see something that can’t be done, we jump in fully committed to do it. We push the limits of science and technology. We redefine partnership through deeper, more meaningful collaboration. It’s how we’ve approached our calling since 1946. And why today you’ll find our filtration, separation and purification solutions at work in so many places. From life-saving gene therapies to airplane engines. Hydraulic systems to injectable medications. Scotch. Smartphones. OLED screens. Paper. Everyday Pall is there, helping protect critical operating assets, improve product quality, minimize emissions and waste, and safeguard health. No matter what, no matter where, we innovate and collaborate to deliver the one thing our customers need most:
Pall Corporation provides critical filtration, separation, and purification solutions to meet the demanding needs of a broad spectrum of life sciences and industrial customers around the globe. Across 80 locations and 10,000 people worldwide, we are unified by a singular drive: to solve our customers’ biggest fluid management challenges. And in doing so advance health, safety, and environmentally responsible technologies. Together, our Life Sciences and Industrial teams serve a diverse range of customers including biotechnology, pharmaceutical, medical, food and beverage, laboratory, microelectronics, aerospace, fuels, petrochemical, chemical, automotive and power generation industries. Our industry-leading technologies and solutions are at work in countless applications, protecting critical operating assets, improving product quality, safeguarding the health, and minimizing emissions and waste
For more info, please check: https://www.pall.com/en/biotech.html
P95 is a global company with a headquarter in Belgium. Our local and regional offices are located in the Netherlands and Colombia, soon in Thailand.
P95 delivers cutting-edge expertise in epidemiology and pharmacovigilance. We are passionate about healthcare and help our customers with innovative medical research.
Our team is comprised of epidemiologists, pharmacovigilance specialists, biostatisticians, data scientists, medical writers, IT engineers and project managers. We are an international team working from more than 17 countries.
P95 projects are largely focused on a broad range of infectious diseases and vaccines. However, we offer customized services upon request.
The world’s first “Vial-to-Harvest” Vaccine manufacturing platform with Linear scalability & ultimate process efficiency.
With decades of developmental efforts & experience in Bioprocess Engineering, we have solved the most critical problems of adherent cell culture processing i.e. 1) Lack of process scalability 2) Efficiency in terms of time to market 3) Affordability in terms of cost reduction in manufacturing process.
At OmniBRx, we have invented a novel bioreactor technology for large-scale biologics / vaccines production and stem-cell therapy use. The technology provides 10X Scalability, 6X efficiency and up to 90% cost reduction during upstream manufacturing processing.
Our patented “CellBRx®️” single-use bioreactors technology is the first-of-its-kind bioreactor devices offering a fully automated and robust platform for vaccine manufacturing with linear scalability of up to 200L bioreactor volume accommodating 1500 m2 of surface area per single-use bioreactor. The proprietary DBR technology employs parallel discs stacked on multiple shafts and the intermingling rotational arrangement of the discs ensures efficient mixing and homogeneity throughout the cell carrier matrix.
With the integrated seed-train development protocol, the technology becomes the first ever close-circuit fully-automated Vial-to-Harvest production platform. The CellBRx bioreactors can grow cells in high densities and recover them efficiently with complete end-to-end process automation.
Nucleus Network, Australia and USA’s Premier Phase I Specialists
Nucleus Network is the only Phase I clinical trial specialist with phase I units in both Australia and the United States. We have three units with 220+ beds and conduct a broad range of early phase clinical trials including FIH, DDI, TQT, Vaccine, Renal/Hepatic Impairment and Biosimilars.
The Australian clinical trial landscape allows global biotechs to advance their early phase clinical programs faster (Rapid Review cycles), easier (No IND), cheaper (43.5% Tax Incentive) and to the same quality standard (ICH/GCP) as studies performed in the USA.
We are Australia’s largest Phase I clinical trial provider with two clinics located in the major Australian cities of Melbourne and Brisbane enabling access to >50% (multiples more than any other Phase I group) of the population. Our large molecule Center of Excellence in Brisbane has been dedicated to development of New Biological Entities, Biosimilars and Vaccines for more than 20 years. This specialization leads to better recruitment outcomes for our sponsors and their programs.Our US clinic resides in the biotech hub of Minneapolis, Minnesota enabling us access to a total of more than 18 million people across all three sites.
Operating in the two global regions where a majority of Phase I studies are performed allows our sponsors to exceed their Phase I value inflection targets rapidly, efficiently and meet international quality standards allowing progression into Phase 2 and beyond.
Established in 1997, Novotech is a global CRO recognized for its partnership with sponsors in clinical trial development and management. The Company offers a comprehensive suite of services, including laboratories, Phase I facilities, drug development consulting, and regulatory expertise, Novotech has executed over 5,000 clinical projects, spanning Phase I to Phase IV trials and bioequivalence studies.
With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech supports clinical trials across Asia Pacific, the United States, and Europe. Leveraging a vast global footprint, deep relationships, and a robust operational framework, Novotech enables small to medium-sized biotech, biopharma, and pharma sponsors to accelerate the speed and scope of their clinical development endeavours.
Discover more at www.novotech-cro.com.
Novo Nordisk Pharmatech A/S is a global and leading manufacturer of pharmaceutical ingredients for the pharmaceutical and biopharmaceutical industries. The company specialises in Recombinant Insulin and cGMP manufactured quaternary ammonium compounds (Quats).
The mission is to enable better medicines by providing sustainable pharmaceutical materials through innovative and customised solutions. Novo Nordisk Pharmatech helps the world´s largest pharmaceutical and biopharmaceutical industries reducing their risk for raw materials by using pharma-grade products with a high level of consistency, purity, quality, and reliability.
Novo Nordisk Pharmatech´ s high purity, non-therapeutic Insulin is sourced directly from parent company Novo Nordisk, the world’s largest insulin producer. Recombinant Insulin stimulates the proliferation of cells, enhances the yield, and is a key component in serum-free growth media for mammalian cells. It is used to manufacture monoclonal antibodies, virus vaccines, gene therapy products and other biological drug products approved by regulatory bodies worldwide, including FDA and EMA.
Novo Nordisk Pharmatech manufactures Quats in an unequalled, full cGMP grade, ensuring exceptionally high purity and batch-to-batch consistency. Benzalkonium Chloride, Cetrimide and Cetrimonium Bromide/CTAB) is suited for a wide range of pharmaceutical applications that require high purity and quality, such as vaccine production. And as preservatives (excipients) or APIs in many ophthalmic, nasal, oral and topical drugs and in various solutions, ointments, gels, and creams.
More than 70 years of experience has provided the know-how to ensure maximum product purity and keeping impurities to even lower levels than pharmacopeial standards. This has made the company a leading global supplier of high-quality ingredients – enabling the customers to make even better medicines.
Novo Nordisk Pharmatech A/S is a global and leading manufacturer of pharmaceutical ingredients for the pharmaceutical and biopharmaceutical industries. The company specialises in Recombinant Insulin and cGMP manufactured quaternary ammonium compounds (Quats).
The mission is to enable better medicines by providing sustainable pharmaceutical materials through innovative and customised solutions. Novo Nordisk Pharmatech helps the world´s largest pharmaceutical and biopharmaceutical industries reducing their risk for raw materials by using pharma-grade products with a high level of consistency, purity, quality, and reliability.
Novo Nordisk Pharmatech´ s high purity, non-therapeutic Insulin is sourced directly from parent company Novo Nordisk, the world’s largest insulin producer. Recombinant Insulin stimulates the proliferation of cells, enhances the yield, and is a key component in serum-free growth media for mammalian cells. It is used to manufacture monoclonal antibodies, virus vaccines, gene therapy products and other biological drug products approved by regulatory bodies worldwide, including FDA and EMA.
Novo Nordisk Pharmatech manufactures Quats in an unequalled, full cGMP grade, ensuring exceptionally high purity and batch-to-batch consistency. Benzalkonium Chloride, Cetrimide and Cetrimonium Bromide/CTAB) is suited for a wide range of pharmaceutical applications that require high purity and quality, such as vaccine production. And as preservatives (excipients) or APIs in many ophthalmic, nasal, oral and topical drugs and in various solutions, ointments, gels, and creams.
More than 70 years of experience has provided the know-how to ensure maximum product purity and keeping impurities to even lower levels than pharmacopeial standards. This has made the company a leading global supplier of high-quality ingredients – enabling the customers to make even better medicines.
Novartis Global Biotech Cooperations is a Contract Development and Manufacturing Organization that helps customers around the world produce and manufacture life-changing biotechnological products – always meeting the highest standards in quality and regulatory compliance. Our capabilities ranges between Plasmid DNA, RNA, Cell & Gene Therapy, Microbial Manufacturing, Mammalian Cell Culture, Fill & Finish, Viral Vector and other innovative technologies. We’re a global team of scientific, economic and manufacturing experts, supported by Novartis – a company with over 40 years’ experience in biologics manufacturing.
https://www.novartis.com/
Nanghavi is a Joint Venture between Sweden based R&D company Nanologica and an Indian family owned business by the Sanghavi family, thereby deriving the name “NANGHAVI”.
We are in the business of manufacturing Analytical, Semi Preparative and Prep HPLC columns by. Our in-house capabilities boasts of manufacturing the silica, functionalizing it, packing the HPLC column & marketing and selling them.
We have an end-to-end capability of manufacturing from the raw material of spherical silica to the HPLC columns itself, we can have complete control over quality of the end product.
N-SIDE is a deeptech company that empowers organizations in the life sciences to make better decisions and optimize the use of critical resources. We’re doing so by combining deep industry expertise with applied mathematics and artificial intelligence into easy to use and cutting-edge software that transforms uncertainty and complexity into deterministic outcomes. We are an active player in clinical trial supply chain management for over 20 years and have the majority of the top 20 pharmaceutical companies as clients.
With our software solution, the N-SIDE Suite, and expert services, we streamline the clinical supply of pharmaceutical and biotech companies by accelerating clinical plans, mitigating risks and curbing drug waste. We empower clinical leaders to make better, faster and safer decisions for patients waiting for life-changing medications.
Founded in 2001, Mycenax Biotech Inc. (MBI) is a CDMO company offering integrated services for the development and manufacturing of biologic products, including cell line generation, process, formulation, and analytical method developments, GMP production for both mammalian and microbial systems, and fill-finish for both liquid and lyophilized forms.
MBI has extensive experience in developing biologic products for our clients around the globe. Ranging from small peptides, fusion proteins, and monoclonal antibodies, to cell therapy products, we provide our clients with time- and cost-effective services through our high-standard technology platforms and PIC/S GMP certified manufacturing facility. For the cell line development, we recently introduced the Beacon® Optofluidic System (Berkeley Lights, US) to streamline the workflow and provide strong evidence for monoclonality. For process development, we are pioneered in developing continuous bioprocess. For GMP manufacturing, our 2 nd GMP facility, which hosts 2 production lines with up to six 2,000L bioreactors will be completed in mid-2021 to further expand our GMP production capacity.
With our innovative technology and qualified GMP facilities, we are the best partner for clients worldwide for developing biologic products at all developmental stages.
For more information, please visit our booth or website at: http://www.mycenax.com.tw/en
JNC CORPORATION / MR SANGHAVI & CO. We are in the business of providing Biotech, Pharma, Fine Chemicals & Academia solutions. With state of the art chromatography bulk media, resins, gels & equipment’s from the world’s best companies, we offer the best technical solutions & support. The Cellufine™ product line offers a broad range of chromatography resins for the purification of proteins, enzymes, and biomolecules. The media based on spherical cellulose beads, exhibits high chemical stability / mechanical strength, higher flux and inherently bio-compatible. Applications include protein / polysaccharide purification, endotoxin removal, and used worldwide purifying vaccines, therapeutic enzymes, and virus concentration / purification. Cellulose media have significantly lower Leachable than comparable polymeric beads. Gel Filtration, IEX, Affinity, and HIC media available for broad range of biomolecules and applications. Cellufine customizes media / ligands, bead sizes for challenging purification process. Besides growing and consolidating the business of international marketing of industrial products and chemical specialties, we undertake backward/forward integration activity to produce tailor-made value-added specialty products. “Our mission is to become a benchmark organization in this line of business by striving consistently to develop our organization, professional skills & infrastructure as to be highly effective in this competitive environment.” Mr. Rajiv Sanghavi Director JNC CORPORATION/MR SANGHAVI & CO. 28, Sarvodaya Industrial Estate, Near Paper Box, Off. Mahakali Caves road, Andheri East, Mumbai – 400093 Mobile : +91-9323990409 Email : rajiv@mrsanghavico.com Website : www.mrsanghavico.com
From our scientists and engineers to our service and support teams, we’re passionate about equipping researchers with next-generation technology that advances scientific discovery. Our customers are at the heart of all we do, inspiring innovative solutions that unravel the complexity of biological systems and support the development of new therapeutics, to improve the quality of human life worldwide. We are Molecular Devices. Helping scientists harness the full potential of biology since 1983.
Mitsui Chemicals is one of Japanese leading chemical companies, providing many world-class products to over 160 companies in 30 countries. Among them, InnoCell™ is one of the latest innovations for the biopharmaceutical industry. By making the base of the cell culture vessel from our material, it is possible to efficiently supply cells with approximately 200 times more oxygen than when using a conventional culture plate.
Merck, a life science leader, is a business of Merck KGaA, Darmstadt, Germany. Our products and services help you safely and efficiently develop and manufacture therapeutics.
Our BioReliance® Biosafety Testing Services offer comprehensive and integrated services that support every phase of the testing, development and manufacturing process.
Your Therapy, Our Priority
Your Trusted Partner for Innovative Biosafety Testing, Cell Banking, Viral Clearance and Product Characterization
Visit our Merck booth.
Speak to us, and learn more:
www.sigmaaldrich.com/
About Merck
Merck, a leading science and technology company, operates across life science, healthcare and electronics. To the life science industry, we provide solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.
The Millipore® portfolio of Merck offers an ecosystem of industry-leading products and services, spanning preparation, separation, filtration and monitoring, as well as clinical and commercial biomanufacturing CTDMO services – all of which are deeply rooted in quality, reliability and time-tested processes. The SAFC® portfolio of Merck offers customized and ready-to-use raw material solutions, backed by deep regulatory expertise. Our proven products, expert services and regulatory and application expertise are a strong foundation you can rely on to consistently perform at the highest level.
For more information, please visit https://www.sigmaaldrich.com/products/pharma-and-biopharma-manufacturing
“An organization taking pride in providing engineering and construction project management consultancy (PMC) for greenfield and brownfield industrial high-tech projects. Leveraging on established network among investment agencies, industrial parks and local authorities, Medhini is well positioned to support projects from early inception such as site selection, project charter initiation and concept development. Working with various partners, we are able to initiate an early start and avoid regulatory hiccups. Added value includes Industry 4.0 implementation support, lean construction strategies, training programs with local and international universities for capacity building, media engagement in science communications among others.
We have also partnered and represent DD Enterprise for the ASEAN region. DDE is a leading enterprise engaged in designing, manufacturing, qualification and commissioning of sterile process systems. By envisioning smarter ideas, greener technologies and solutions, DDE have been redefining boundaries in the high purity business while working with bio-pharma, vaccine and sterile formulations industries for the last 25 years. DDE products offer consistent quality, reliability and repeatability as they use customized designs, state of the art design tools, best manufacturing practices, highest quality components integrated with fully automated and intelligent control systems and full cGMP documentation package.”
MasterControl Inc. is the leading provider of cloud-based quality and compliance software for life sciences and other regulated industries. Our mission is the same as that of our customers – to bring life-changing products to more people sooner.
You can use the MasterControl Product Lifecycle Excellence™ platform to digitize, automate and connect quality and compliance processes at every step – from concept to commercialization. Join over 1,000 companies worldwide that rely on MasterControl solutions to achieve new levels of operational excellence across product development, clinical trials, regulatory affairs, quality management, supply chain, manufacturing and postmarket surveillance.
Learn more at www.mastercontrol.com
Marken is a wholly owned subsidiary of UPS and is the essential clinical part of UPS Healthcare. With Marken, BOMI Group and Polar Speed included, the UPS Healthcare network staffs 199 locations with 10,000+ employees worldwide. Marken offers a state-of-the-art GMP-compliant depot network and logistic hubs for clinical drug product storage and distribution in 59 locations worldwide, while maintaining the leading position for Direct-to-Patient and Home Healthcare services, biological sample shipments and biological kit production. Marken’s dedicated 2,400+ staff members manage 154,000 drug product and biological sample shipments every month at all temperature ranges in more than 220 countries and territories and have orchestrated 14,000+ home healthcare visits. Additional services such as cell and gene supply chain services, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.
Link to your website – https://www.marken.com/
Malaysia Association for Cell Therapy (MACT) was conceived through the joint efforts of cell therapy industry, physicians and researchers who share a mission to provide scientifically credible and medically appropriate CELL THERAPIES to informed patients /consumers, and it is motivated by the recognition of cell therapy as an important industry in our country, Malaysia, as well as by the fact that cell therapy is the next rising industry to emerge from the impressive advances in life science research especially since the past 2 decades. MACT was officially formed on 15th February 2012 by the Registrar of Societies, Malaysia. Members of MACT are companies who are involved in bio-banking to immune cells and cell culture & stem cell laboratory as well as stem cells therapeutic research. The formation of MACT is not just motivated by the increasing recognition of cell therapy as an important industry to our country, but also as a rigorous science based discipline with its own body of requisite knowledge and skills those working in the field are expected to possess to demonstrate professional competence.
Lumis International GmbH was founded in 2013 with the goal to act as a bridge to Europe for clinical research activities. The company is specialized in providing legal representation services and regulatory consulting for biopharmaceutical and medical device companies who intend to develop their product in the European market but are located in non-EU countries around the globe.
Lumis Life Science Consulting GmbH was founded in 2020 as an independent subsidiary of Lumis International to provide customer-tailored consulting and solutions for clinical vendor selection and management, clinical trial oversight, quality management, and training.
As a leading Contract Development and Manufacturing Organization (CDMO) in CGT, we provide comprehensive solutions that accelerate the development, manufacturing and commercialization of life-changing therapies.
Website: https://www.lonza.com/cell-
As a leading Contract Development and Manufacturing Organization (CDMO) in CGT, we provide comprehensive solutions that accelerate the development, manufacturing and commercialization of life-changing therapies.
Website: https://www.lonza.com/cell-
Our innovative life science, applied science, and clinical products are now found under the Applied Biosystems™, Invitrogen™, Gibco™, Ion Torrent™, and Molecular Probes™ brands.
Korea Biotechnology Industry Organization (KoreaBIO) is an association established as a result of the merger between three different industry associations in the biotechnology field in November 2008. KoreaBIO promotes communications among all bio-industry-related organizations and is striving to create a sustainable biotechnology industry ecosystem.
KoreaBIO is a central organization with around 500 members from major pharma & biotechnology companies to special members, representing the biotechnology industry of Korea. KoreaBIO also develops various training and policy-making programs to serve the member companies more efficiently, and also promotes cooperation, investment relations, and technological collaborations around the world.
Körber Business Area Pharma delivers the difference along the pharma value chain with our unique portfolio of integrated solutions. With our software solutions we help drug manufacturers to digitize their pharma, biotech and cell & gene factories. The software product Werum PAS-X MES is recognized as the world’s leading Manufacturing Execution System for the pharma & biotech industry. Our data analytics and AI solutions accelerate product commercialization and uncover hidden business value.
Körber Pharma Software is the leading international provider of Manufacturing Execution Systems (MES) and manufacturing IT solutions for the pharmaceutical and biotech industries. We are your contact when it has to do with pharmaceutical products. As a leading system supplier, we advise you on everything from development through manufacturing and inspection all the way to the packaging of your products.
For more details, go to www.koerber-pharma.com
For more than 85 years, Kerry has provided integrated solutions for the world’s leading biotechnology customers. We are a global leader in innovation and applications for cell culture, diagnostic, and fermentation media. Every day we expand our capabilities to meet the changing needs of the biotech market. We provide cell nutrition supplements including protein hydrolysates, yeast extracts, recombinant proteins, and complex systems that maximize yields and cell performance in biotechnological production systems. We have the vast global resources and technical platform to deliver consistent, high-quality products backed by unparalleled service, technical support, and formulation customization capabilities
Kemwell is a leading biologics CDMO in Asia which provides services to global biopharmaceutical organizations. Kemwell, having established in 1980, has had long-term associations with pharma majors for small molecule CDMO. In 2016, Kemwell divested its small-molecule global business to Recipharm with an aim to focus on biologics CDMO business. The facilities in Bangalore, India consists of a cGMP drug substance manufacturing suite with over 4000L bioreactor capacity in operation, a sterile fill and finish suite for cGMP drug product manufacturing and process development laboratories to support production of protein therapeutics using mammalian expression systems – mAbs, bi-specifics, fusion proteins, etc. Kemwell is capable of supporting novel, bio-better and biosimilar program’s preclinical development, clinical development, cGMP clinical and commercial manufacturing.
For more information, visit http://www.kemwellbiopharma.com/
JSBio is committed to becoming a world-class leader in cell culture technology and a supplier of high-quality culture medium products. It is one of the few teams in China that has a complete CMC production and operation system. Since its establishment, JSBio has always adhered to the concept of “Quality First, Customer Focused” by providing high-quality products for partners in the antibody/recombinant protein and human/veterinary vaccine industries. From basic research to commercial stages of therapeutics and vaccines, JSBio’s products and services meet the highest quality and regulatory standards of the industry.
The leadership team of the JSBio are world-class culture medium manufacturers and biopharmaceutical executives. Since the establishment of the company, JSBio has served 200+ antibody/recombinant protein, human/veterinary vaccine customers, including 100+ Phase Ⅰ/II clinical projects, 30+ phase III clinical projects, and 20+ commercialization phase projects.
After ten years of development, JSBio’s business has expanded to nearly 30 provinces, municipalities and autonomous regions in China, and has also extended to overseas markets such as Asia-Pacific, Europe and the United States. JSBio provides customers with high-quality culture medium products and related cell culture process services that meet multinational standards, and has also enabled the development of the biopharmaceutical industry.
Since its inception, Hanbon Technology has been adhering to the original intention to provide biopharmaceutical users with drug purification equipment and services based on chromatography technology. The main products are: Biopharmaceutical downstream purification equipment, Industrial preparative liquid chromatography systems, Supercritical fluid chromatography systems, Continuous chromatography systems, Small nucleic acid synthesis and purification equipment, and can provide users with chromatography products as the core of the overall solutions and services. For more than 20 years, Hanbon has been following the wave of biopharmaceutical development, constantly developing new products and meeting the emerging needs of the market, providing R&D and production equipment for synthesis, purification and delivery of emerging small nucleic acid drugs, mRNA vaccines, cell therapy drugs, etc.
Website link: http://www.hanbon.com.cn/en/
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients.
Our purpose is to be a catalyst for innovation in healthcare, to drive healthcare forward every day, and make the extraordinary possible for patients. We do this by helping to speed drug development, ensuring product quality and safety, improving commercial effectiveness, getting the right treatments to patients, improving access and delivery of healthcare, and ultimately driving better health outcomes. And we always strive to be extraordinary – every step of the way.
Protecting Life’s Most Precious Cargo for 25 Years
We have been designing and manufacturing environmentally sustainable and regulatory compliant sample transport and temperature-controlled packaging for 25 years.
Patient safety is always at the forefront of our product development. Ensuring your pharmaceutical products and biological samples arrive at their destination with their integrity intact is paramount.
As well as offering a diverse range of sample transport and temperature-controlled packaging solutions, our expert Technical Services team and ISTA-certified laboratory ensure we can design, test and qualify your packaging with your specific payload and shipping lane in mind.
Our vision is to empower decision-making in the processing industries with innovative simulation tools and tailored services to contribute to a sustainable future worth living in. We believe that simulation offers unparalleled levels of insight into complex processes and their prospective behavior. Leveraging this potential means making more confident decisions in process development and plant operations. It means that we can learn from tomorrow, today. To achieve these ambitious goals, we have organized the INOSIM Group as a Software and a Consulting branch.
INOSIM SOFTWARE
For nearly twenty years now, INOSIM Software has been a synonym for high-end performance in the simulation solutions market. During that period, we have set technological standards in many process industries: According to our customers, there is no other simulation tool offering the flexibility and comprehensiveness provided by our scalable standard software and its extensions for optimization and statistical analysis. INOSIM software has provided solutions for a variety of companies in the processing industries. Historically, our core customers have been chemical companies, but in the recent years, many pharmaceutical and biotechnical companies have recognized the potential of our sophisticated simulation tools. Additionally, several engineering service providers use our tools in their projects. Using our software tools, engineers can handle a wide range of simulation projects. Mainly our products are used to simulate process logistics and execute material flow analysis. In such projects, the entire plant is modeled or extended to simulate plant operations and to analyze the plant’s performance with varying influences such as limited equipment, resources (employees, utilities, logistics, etc.), failures, and/or maintenance. Next to software development and sales, research is an important factor in our strategy to ensure that our software products remain state-of-the-art. Therefore, we are consistently involved in collaborative research projects to create solutions for industrial challenges influenced by the latest in academic research.
INOSIM CONSULTING
INOSIM Consulting is a world-wide engineering service provider with branches in Germany, India, and the U.S. Core activities include the simulation based analysis of complex logistics and production systems in chemical, biochemical and pharmaceutical industries.Additionally, INOSIM Consulting is strongly involved in collaborative research projects about resource and energy efficiency in production processes. INOSIM Consulting is closely connected to INOSIM Software and is responsible for first-level support and training on INOSIM software solutions.
If you would like to know more, please visit our website at www.inosim.com or give us a call at +91 9766 331 092.
Innoforce enables the innovation and global supply of plasmid DNA, RNA, cell and gene therapeutics, powered by a world-class manufacturing and development hub. With extensive expertise in process development and manufacturing of Advanced Therapy Medical Products (ATMPs), Innoforce can be a trusted partner for your innovative ATMP projects from R&D through commercialization.
DBT/Wellcome Trust India Alliance (India Alliance) is an independent, dynamic public charity that funds research in health and biomedical sciences in India. India Alliance invests in transformative ideas and supportive research ecosystems to advance discovery and innovation to improve health and well-being. India Alliance encourages diversity, inclusivity, and transparency in science and works to facilitate engagement of science with society.
IMCD Korea was established in 2019 after combining forces with Whawon Pharm Co., Ltd. It has since developed into a leading solution provider for specialty chemicals and ingredients, providing the best in-class sales, marketing and technical services to customers and principal suppliers in South Korea.
IKA is a leading manufacturer of laboratory equipment, analytical and process technology. Headquartered in Germany, we opened our first subsidiary in the U.S. in 1985. After a decade of steady growth in the world markets, the first Asian subsidiary was founded in Malaysia in 1995 to serve the booming Asian market. From then onwards, the IKA Group kept growing and continues to grow to this day. In 1998, the Chinese subsidiary in Guangzhou was added, which has since expanded to include sales offices in Beijing and Shanghai. IKA Works Japan and IKA India, as well as branches in Brazil, South Korea, Vietnam, Great Britain, Poland, Thailand and Turkey followed some time later. Today, a total of 15 branches in 13 countries ensure excellent service worldwide.
Our website: www.ika.com
IDBS provides purpose-built software solutions to address the data management challenges prominent across the BioPharma lifecycle and supply chain. Leveraging more than 30 years of experience in life science informatics, IDBS is uniquely positioned to deliver a portfolio of innovative BioPharma knowledge management technologies to streamline the capture, analysis, reporting and sharing of data required to accelerate the next generation of life-changing therapies.In addition to our signature E-WorkBook software, IDBS introduces the industry’s first BioPharma Lifecycle Management (BPLM) solutions. Cloud-native and analytics-centric, IDBS Polar and Skyland PIMS platforms enable customers in research, development and manufacturing to efficiently and compliantly access critical data and insights to make faster, smarter decisions with greater confidence.
We are a leading distributor of innovative scientific solutions. We started in 1991 and have been growing ever since. Our product and application specialists have a scientific education and a PhD degree and therefore understand your specific needs. We speak the same language when it comes to your individual solution! We focus on sales and professional services for high quality equipment in the fields of microbiology, cell biology and biotechnology in Europe.
The Hope Consortium is an Abu Dhabi-based public-private partnership offering a unique end-to-end supply chain solution capable of delivering large quantities of COVID-19 vaccines, from production to patients, anywhere in the world, safely, transparently and efficiently. The Hope Consortium has pooled the collective expertise of its partners to provide multi-faceted logistics services to handle transport, demand planning, sourcing, training, and digital technology infrastructure, to facilitate vaccine availability across the world. The Hope Consortium’s founding partners consist of the Department of Health Abu Dhabi, Etihad Cargo, Abu Dhabi Ports, Maqta Gateway, Rafed, and SkyCell.
Honeywell’s advanced automation and process controls help Life Sciences manufacturers maintain auditability and traceability, optimize production, and increase speed to market while focusing on quality and repeatability. Data capture, recording and reporting solutions simplify and safeguard cGMP compliance. Fast track your production with flexible and scalable systems, insight into upcoming events or delays, easy troubleshooting, remote asset management, and embedded cyber security.
For more information, visit: www.honeywellprocess.
HiMedia Laboratories Private Limited is an Indian origin Bioscience company headquartered in Mumbai, with presence across 150 countries. Its division, Animal Cell Culture has expertise in production of cell culture medium for mammalian & insect cell lines, in powdered and liquid formulations. Comprehensive design of experiments, raw material qualification and media production using automation and customization are our strengths. We supply serum free media for CHO, Vero, MDCK, HEK, PK-15, Vero, MRC-5 and BHK cell lines, most widely used for industrial production of recombinant proteins and vaccines. In addition, we also supply multi-compendial biochemicals and growth factors for Cell Culture.
To know more about our company please visit our website: www.himedialabs.com
Harro Höfliger develops and manufactures production and packaging equipment for customers around the world. Pharmaceutical and medical companies as well as brand item manufacturers for consumer and home care products trust in our highly specialized process solutions. Our portfolio of machines covers every industrialization level, and our broad range of services focus on the entire product life cycle
Halo Labs knows aggregates and particles. The Aura can count and characterize subvisible particles and tell you if they are aggregated drug product, excipients, or external contaminants. A simple, plate-based approach enables low-volume, high-throughput, fully automated particle imaging and analysis at any stage from developability assessment through quality control.”
Website: https://www.halolabs.
Gerresheimer is the global partner for pharmaceutics, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging solutions and drug delivery systems. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence and concentration on quality and customer focus. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia. Gerresheimer produces close to its customers worldwide with around 11,000 employees and generated annual revenues in 2021 of around EUR 1.5b. With its products and solutions, Gerresheimer plays an essential role in people’s health and well-being.
GenScript ProBio is the subsidiary of GenScript Biotech Corporation, proactively providing end-to-end CDMO service from drug discovery to commercialization with proactive strategies, professional solutions and efficient processes in cell and gene therapy (CGT), vaccine, biologics discovery and antibody protein drug to accelerate drug development for customers. GenScript ProBio has established companies in the United States, the Netherlands, South Korea, Shanghai, Hong Kong, Nanjing and other places to serve global customers, and supported customers in the United States, Europe, Asia Pacific and other regions to obtain more than 30 IND approvals.
GenScript is a global biotechnology group. GenScript’s businesses encompass four major categories based on its leading gene synthesis technology, including operation as a Life Science CRO, enzyme and synthetic biology products, biologics development and manufacturing, as well as cell therapy.
Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 300,000 customers from over 160 countries and regions around the world have used GenScript’s premier, convenient, and reliable products and services.
GenScript currently has more than 3000 employees globally, 33% of whom hold master’s and/or Ph.D. degrees. In addition, GenScript has a number of leading commercial technologies developed in the fields of synthetic biology, immunotherapy, antibody design, chemical synthesis and bioinformatics, including more than 70 patents and over 200 patent applications. As of January 2019, GenScript’s products and services have been cited by 36,500 scientific papers worldwide.
GenScript is committed to striving towards its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology.
For more information, visit www.genscript.com
Principal Contact Name: Cassie Yap/ Boon Hwa Tay
Email Address: cassie.yap@genscript.com / boonwha.tay@genscript.com
Position: Marketing Supervisor / Marketing Specialist
Complete Digital Marketing Solution Biopharma and Life Science
GeneOnline is a leading biotech media platform that offers in-depth insights and news to various users and businesses globally, focusing on the pharmaceutical, biotechnology, and life sciences industries. Our coverage is delivered across multiple channels in English and Chinese. GeneOnline is your first stop for the latest biotech insights and networks.
GEA is one of the world’s largest systems suppliers for the food, beverage and pharmaceutical sectors. Our portfolio includes machinery and plants as well as advanced process technology, components and comprehensive services. Used across diverse industries, they enhance the sustainability and efficiency of production processes globally.
Gamma Biosciences is a leading life sciences company providing products and services to support the development and manufacturing of advanced biologic therapies. Our operating companies are committed to advancing the science and art of bioprocessing by delivering market-ready innovation and expertise that helps our customers, mainly biopharmaceutical companies and contract development and manufacturing companies, safely bring therapies to patients more quickly and efficiently. Gamma is a global company with offices and major manufacturing facilities in North America, the U.K. and Belgium.
G-CON Manufacturing designs, builds and installs prefabricated cleanrooms. G-CON’s POD portfolio provides cleanrooms in a number of dimensions for a variety of uses, from laboratory environments to personalized medicine and production process platforms. G-CON POD cleanrooms surpass traditional cleanroom structures in scalability, mobility and the possibility of repurposing once the production process reaches its lifecycle end.
For more information, visit: www.gconbio.com
By leveraging FUJIFILM Group’s collective bio-related technologies, including Wako Pure Chemical and Irvine Scientific,FUJIFILM continues to accelerate the growth and provide broad product portfolio in bio-medical through synergies and collaborations.
FUJIFILM Wako Pure Chemical (FFWK) is a world-wide supplier of high purity chemicals and reagents based in Japan.
FFWK has various raw materials including cell culture media for vaccine production and QC/QA testing products,
and provides services to support the process from the research stage to the commercial stage of pharmaceutical manufacturing.
Our product portfolio comprises a range of highly complex biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs. Within biopharmaceuticals, Fresenius Kabi offers, among others, biosimilar drugs with a focus on autoimmune diseases and oncology. Our clinical nutrition offering includes a wide selection of enteral and parenteral nutrition products. In the segment of medical technologies, Fresenius Kabi offers vital disposables, infusions pumps, apheresis machines, cell therapy devices, and more.
Website: Home – Lovo (chooselovo.com) | https://choosecue.com/
The Foxx story begins in 2008, where President & CEO Thomas Taylor started the company as a family operation based out of his house. Tom founded Foxx on five key principles: Innovation, Quality, Customer Service, Growth, and Culture. The Foxx culture fosters a positive and collaborative work environment, with dedicated employees who share a common vision, and genuine desire to provide our customers with the best service possible. Our passion stems from our people.
ForteBio accelerates discovery and development of vital medicines that cure diseases. We do that by enabling life science researchers to rapidly analyze molecules involved in biological processes, by providing best-in-class products, by knowing the science behind our customers’ research, by providing first-class service, and by being a trusted partner in finding solutions to research challenges.
Fluid Air PolarDry®: Electrostatic Spray Drying
The solution to low-temperature powder processing.
PolarDry is a high-throughput alternative to lyophilization or freeze drying. The low-temperature electrostatic spray dryers are ideal for heat-sensitive material, including living microorganisms, probiotics, and proteins. This breakthrough technology enables superior protection along with advanced aqueous and lipid microencapsulation.
Additionally, Fluid Air also produces robust, high-quality Fluid Bed Systems, High-Shear Granulators, Size Reduction Mills as well as Process control and tablet coating optimisation systems. Fluid Air is proven to increase efficiency in the solid dosage and biologic industry both in Australia and around the globe.
FedEx Corp. (NYSE: FDX) provides customers and businesses worldwide with a broad portfolio of transportation, e-commerce and business services.
With annual revenue of nearly $90 billion, the company offers integrated business solutions through operating companies competing collectively, operating collaboratively and innovating digitally as one FedEx. Consistently ranked among the world’s most admired and trusted employers.
FedEx inspires its more than 500,000 employees to remain focused on safety, the highest ethical and professional standards and the needs of their customers and communities. FedEx is committed to connecting people and possibilities around the world responsibly and resourcefully, with a goal to achieve carbon-neutral operations by 2040. To learn more, please visit fedex.com/about.
To learn more on Healthcare solution, please visit Healthcare solutions
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.
We, Excel Biomedical, Inc., were founded in 1995. As a proactive company, we took the very first step to introduce immunology-related reagents to Taiwan. Currently, we as the distributor of life science products, encompassing all fields of immunology, cell biology, and biomedical science. By introducing the world’s top companies’ products into Taiwan, such as Abcam, BioLegend, Cayman Chemical, PeproTech and NIBSC, etc to fulfill research needs. Also, we provided professional technical support service to our valuable customers.
Throughout these years, as the agency of a broad range of life science reagents in Taiwan, we established our good reputation and high brand value in the market. The the company philosophy is to take responsibility for developing a positive relationship and providing a good experience for each customer by giving efficient,
professional and prompt service.
For more information, please visit: https://www.exbio.com.tw/
Evonik is one of the world leaders in the specialty chemicals industry. Active in more than 100 countries around the world, Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. We contribute small amounts of material that make a big difference. We provide the highest quality cell culture media ingredients for biologic drugs development & manufacturing, produce lipid nanoparticles essential in mRNA-based COVID-19 vaccines, make tires more fuel-efficient, and animal feeds healthier. As one of the key growth regions, Evonik has a strong production and R&D footprint in Asia Pacific. With over 5,000 employees at more than 50 production sites, the region contributed to €3.4 billion sales in 2021.
At Evonik, we offer high-quality cell culture solutions to pharmaceutical and biotech companies to help them boost cell culture performance in the manufacturing of therapeutic proteins like monoclonal antibodies, as well as in the production of viral vectors such as the adeno associated viral (AAV) vectors for gene therapy.
Commercially proven for reliable media performance across countless biological programs, our cQrex® portfolio features a range of peptides and keto acids designed to address key issues in mammalian cell culture.
Our latest offering, plant-derived cholesterol PhytoChol® Biopharma, which has been especially developed for use in animal-free cell culture media formulation, for example in chemically defined media which do not use fetal bovine serum (FBS). In addition, specialty carbohydrates like D-Mannose can be used as alternative energy sources and building blocks for intracellular protein glycosylation, enabling a higher flexibility in the production of therapeutic proteins.
All these cell culture ingredients are non-animal derived, readily available at commercial scale and can be customized to address specific project needs.
Learn more about Evonik’s cell culture expertise at https://healthcare.evonik.com/en/biopharma/cell-culture.
EuBiologics is developing new vaccine products with the goal of distributing safe and effective vaccines that can contribute to the promotion of global public health. In addition, it is a specialized bio company that provides CRMO (Contract Research and Manufacturing Organization) services for various biopharmaceuticals based on advanced facilities suitable for biopharmaceutical research and production, professional manpower, and rich experience in the field. Starting with Euvichol-Plus, which occupies more than 80% of the global cholera vaccine market, EuBiologics is developing new infectious disease preventive vaccines using EuIMT using the immune enhancer EcML and EuVCT technology using the recombinant protein rCRM197.
We have a cGMP-level plant (C Plant & V Plant), and we provide customized CRMO services in consideration of improving product quality and securing competitiveness for the entire production cycle of biopharmaceuticals derived from mammalian cells and microorganisms, from cell line development to GMP production.
Website: www.eubiologics.com
ETBA is a non-profit association governed by the present association statutes as well as the Articles 60 et seq. of Swiss Civil Code. ETBA is a legal entity and is independent from any particular political or religious affiliations. The headquarter of the association is located in Zürich, Switzerland. ETBA aims to enhance the connections and collaborations between Taiwan and European countries in the areas of biotechnology, pharmaceuticals, and medical technology. We believe the advancements in these fields will contribute significantly to improve the qualities of life and make our planet a better place to live.
Website: https://etba.ch/
We Help Bring Life-Saving Treatments to the World
Large cell numbers are needed for the development of cell therapies and stem cell-based drug research applications. By utilizing its strong synergies in cell culture expertise, bioreactor technology, and polymer manufacturing, Eppendorf has emerged as an expert partner for the cultivation of (stem-) cells at large scale.
With our equipment, training programs, and application services, we support scientists in resolving cultivation bottlenecks during the development of cell-based applications from basic research to cell and gene therapy applications. The need for advanced solutions is increasing. With our expertise, we help to stimulate the growth of your cultures and cultivate solutions tailored to your challenges.
Since 1945, the Eppendorf brand has been synonymous with customer-oriented processes and innovative products, such as laboratory devices and consumables for liquid handling, cell handling and sample handling. Today, Eppendorf and its more than 5,000 employees serve as experts and advisors, using their unique knowledge and experience to support laboratories and research institutions around the world.
Envirotainer is the global market leader in secure cold chain solutions for the pharmaceutical supply chain. The company develops, manufactures, and offers leasing of innovative container solutions, including validation, support, and service, for pharma products that require a controlled environment. Thanks to a truly global presence with the world’s active container fleet, the largest network, and an extensive industry expertise, Envirotainer is able to meet the customers’ need for innovative and reliable solutions – available from any location to any destination. The company operates through an open, global network of airlines and forwarders and the headquarters is located outside of Stockholm, Sweden. For more information, please visit www.envirotainer.com.
Endress+Hauser is a global leader in measurement and automation technology for process and laboratory applications. The family company, headquartered in Reinach, Switzerland, achieved net sales of more than 3.3 billion euros in 2022 with a total workforce of nearly 16,000.
Endress+Hauser devices, solutions and services are at home in many industries. Customers thus use them to gain valuable knowledge from their applications. This enables them to improve their products, work economically and at the same time protect people and the environment.
Endress+Hauser is a reliable partner worldwide. Its own sales companies in more than 50 countries as well as representatives in another 70 countries ensure competent support. Production facilities on four continents manufacture quickly and flexibly to the highest quality standards.
Endress+Hauser was founded in 1953 by Georg H Endress and Ludwig Hauser. Ever since, the company has been pushing ahead with the development and use of innovative technologies, now helping to shape the industry’s digital transformation. 8,700 patents and applications protect the Group’s intellectual property.
For further information, please visit www.endress.com/media-center or www.endress.com
Emerson is where technology and engineering come together to create solutions for the benefit of our customers, driven without compromise for a world in action. As a global innovator, Emerson has a deep legacy of solving the most complex challenges facing modern life. We combine advanced technologies, industry-leading expertise and an insatiable curiosity about the world around us to create sustainable solutions for the essential customers we serve.
Our how is complex, but our why is simple and found in our unified global Purpose: We drive innovation that makes the world healthier, safer, smarter and more sustainable. https://www.emerson.com/en-sg/
A world leader in the design and manufacture of high-performance temperature-controlled packaging systems for the transport of pharmaceutical products, EMBALL’ISO is now an expert of turnkey Reuse, Reverse Logistics and Rental solutions.
EMBALL’ISO’s worldwide presence across 4 continents, with 8 production sites (Brazil, China, France, Germany, India, Singapore, UK and the US), 14 Services Centre and collection points in more than 80 countries helps you reuse isothermal packaging while saving time and money.
We supply systems capable of carrying a single vial to airfreight pallet shippers available flat packed or fully assembled in new and innovative Logistics Business models.
EMBALL’ISO delivers quality everywhere, just like you.
Elsevier, a global leader in information and analytics, helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We extract reliable data from scientific literatures to support corporate R&D professionals save time, make better decisions and innovate. Our life science solutions for pharmaceutical customers including, Reaxys, ScienceDirect, Scopus, Embase and Pharmapendium, which combine trusted data and analytics to help you answer critical drug discovery and business questions, including efficiently monitoring post-market drug safety literatures.
https://www.elsevier.com/zh-tw/rd-solutions/pharma-and-life-sciences-solutions
Elomatic, India is a turnkey engineering & consulting company dedicated to the pharmaceutical & biotech industry. It is a Joint Venture of Elomatic Oy, Finland. Elomatic is a multidiscipline industrial engineering, consulting, and software Design Company from Finland and the Pharmaceutical & Biotech sector is the key focused SBU of their process division.
Elomatic provides end to end engineering & consulting solutions starting from concept to commissioning. Broadly, it includes services like Conceptual design, Civil Structural & Architectural design, Basic engineering, Process engineering, Value engineering, Detailed engineering, Procurement assistance, Qualification documentation, FAT & Validation services along with Site management.
At Ellab, our mission is to reduce the time-to-market and risk of product loss for biotech and pharma companies across the globe. We do so through our reliable validation products and field services, continuous monitoring solutions, GMP consulting, and calibration services.
As a validation and monitoring tech and service partner, we help biopharmaceutical companies meet compliance requirements and deadlines today, and tomorrow – allowing us to build confidence in consumer safety together.
Cygnus Technologies, part of Maravai LifeSciences, is the biopharmaceutical industry’s partner in host cell protein (HCP) and other process-related impurity detection and analytics as well as in innovative viral clearance solutions. Cygnus helps companies developing therapeutic proteins, vaccines, antibodies, plasma derivatives and gene therapies to ensure the safety of biotherapeutics prior to human trials, regulatory approval and commercial release.
The Development Center for Biotechnology (DCB)
With over 400 dedicated researchers and state-of-the-art facilities , the Development Center for Biotechnology (DCB) specializes in developing biologics and small molecule drugs , botanical drugs , as well as technologies required for preclinical testing. Our expertise arises from the integration of a number of diverse disciplines , including biology , chemistry , protein purification and engineering , as well as analytical and quality assurance. Established in 1984 by Taiwan’s Ministry of Economic Affairs (MOEA) , Department of Industrial Technology (DoIT) , DCB was initially tasked with establishing the biotechnology industry in Taiwan. Through strategic global alliances and technology transfer agreements , DCB has successfully fostered the development of a complete biotech infrastructure and value chain , as well as a diverse array of applications for use by the private sector. As a result , DCB has become one of Taiwan’s most important research institutes.
DB Schenker is one of the world’s leading global logistics providers — we support industry and trade in the global exchange of goods through land transport, worldwide air and ocean freight, contract logistics and supply chain management.
Our logistics solutions for the Healthcare industry are designed and customized exactly for your requirements. From biopharmaceuticals to medical devices, from PPE to blood plasma, DB SCHENKERlife+ delivers reliability for customers across the industry, including Biopharma, Pharmaceuticals, Animal Health, MedTech, and Consumer Health & Nutrition.
With DB SCHENKERlife+, you can count on us to deliver for you – especially now!
Datwyler is a leading industrial supplier and a key player in the global health care world.
Our state-of-the-art solutions for drug packaging and medical devices, build on over 100 years of experience. Within our healthcare offering, we provide a unique range of products and services including the most advanced elastomer formulations, coatings, aluminum
seals, and processing technologies. Partnering up with the world’s top pharmaceutical and medical companies, we are a vital link and stand by our mission to ensure all patient’s safety and improve patients’ lives.
For more infromation, please visit: https://datwyler.com/
At Cytiva, we believe the key to transforming human health is accessing life-changing therapies. That’s why our nearly 10 000 associates in more than 40 countries are keenly focused on helping researchers, biopharma companies, and drug manufacturers to advance and accelerate therapeutics for people that need them. We’re driven by their desire to achieve better flexibility, capacity, and efficiency in all facets of their work – all the way from discovery to delivery. Learn more at cytiva.com.
Cygnus Technologies, part of Maravai LifeSciences, is the biopharmaceutical industry’s partner in host cell protein (HCP) and other process-related impurity detection and analytics. In addition, Cygnus now provides innovative viral clearance solutions as well.
Cygnus helps companies developing therapeutic proteins, vaccines, antibodies, plasma derivatives and gene therapies to ensure the safety of biotherapeutics prior to human trials, regulatory approval and commercial release. Cygnus provides analytical tools and solutions delivering insights to improve bioprocess development for faster regulatory approval and better clinical outcomes.
CSafe Global, which now includes the Softbox Systems brand of passive solutions, offers a full suite of cold chain shipping solutions and is the only provider of active air cargo solutions as well as passive parcel and cell and gene solutions.
With a robust air cargo container fleet and artificial intelligence lease forecasting system, we can ensure a 100% delivery guarantee on our leased containers. Combined with an unlimited supply of reusable parcel and cell & gene packaging, 24/7 customer and technical service, and real-time shipment visibility, CSafe is well-positioned to be your partner of choice for the cold chain.
CSafe Global Website: https://csafeglobal.
CSafe Virtual Product Tours: https://www.
#
CRYSTE was established in 2009 with manufacturing site at Bucheon city which is 20 minutes away from the capital city, Seoul in South Korea. CRYSTE provides a wide range of reliable laboratory products such as centrifuge, biosafety cabinet and others. Our product are manufactured in the facility complying with ISO 9001 & ISO 13485 and their medical equipments are stringently controlled under the GMP guidelines ensuring that a high level of quality control and assurances implemented every step of the way. CE approval for many of their products confirms their continued commitment to top quality instruments for life science & medical laboratories, ultimately giving greater customer confidence and satisfaction.
CRYOPDP aims to support the health of people around the world by providing global innovative temperature-controlled logistics solutions to the Clinical Research and Cell & Gene Community. Our services ensure the safety and quality of the life science industry, reaching and helping to save millions of lives.
Croda Pharma is a leading partner for the development of excipients and the supply of high purity materials for pharmaceutical formulations. Our drug delivery platforms provide tailored solutions to our customers to develop successful therapies. Ranging from small molecule and protein delivery, nucleic acid delivery through to adjuvant systems, our holistic approach in assisting in the success of drug formulation sets us apart. Providing support, application data, coupled with global manufacturing capabilities and collaboration opportunities make Croda Pharma the partner of choice for development success.
Combining our unique product portfolios and expertise, Croda Pharma and Avanti Polar Lipids are empowering the development and manufacturing of next generation vaccines. With strong expertise in high quality excipients, a culture of innovation and specialist scientific knowledge, we support our customers with the development of new and effective adjuvant systems and ingredients for vaccines.
To find out how we address the challenges of vaccine formulation and our offers, visit www.crodapharma.com.
Clinical Research Network India (CRN India) (A Make In India CRO, Your Vaccine Research Partner)
· Clinical Research Network India (CRN India) is a Make in India CRO with extensive experience in Vaccines, Gene Therapy and Stem Cell Product Development Process.
· CRN India provides comprehensive solutions in Project Management, Medical Writing, Data Management, Regulatory Affairs, and other core research solutions.
· We are specialized in designing, conducting, and managing Phase I to Phase IV clinical trials.
· We have experienced in conducting following Vaccines, COVID Vaccines, Intranasal COVID Vaccines, Pneumococcal (Pediatrics & Adult), Rotavirus, Typhoid, Dengue, Tuberculosis, Malaria, Meningococcal, Japanese Encephalitis, HPV, MR, Oral Cholera, Hep-A, Varicella, Hexavalent, IPV and many more…
· The integration of resources at CRN India enables the highest level of quality research services with passion, knowledge, and integrity that makes it a global leader today.
CPi Biotech is a specialist engineering company and expert in the delivery of bio process single-use skid packages and single-use assemblies. Based in Little Island in Cork, CPi is at the centre of Pharma in Ireland and at the gateway to Europe.
Founded in 2001, CPi has grown to become a leading manufacturer and provider of Single-Use Assemblies and Advanced Bioprocess Skids to the Biopharmaceutical sector in Ireland and has successfully delivered on projects in the European Market. As a private limited company, CPi Biotech is an independent, lean organisation with a client-centric approach, which has been the cornerstone to its success over the past 20 years.
CPi’s single use offering comprises bio process skid systems which are available as standard and fully customisable. Single Use assemblies are manufactured for site wide consumption from upstream to downstream and through to fill finish, all from their state-of-the-art ISO Class 7 cleanroom. CPi offers full project management services and using its technical expertise and deep knowledge of the Single-Use sector, they work collaboratively with their customers in delivering world-class and high-quality Single-Use solutions.
Contact: www.cpibiotech.com
Comecer, an ATS company, is a developer and manufacturer of high-tech systems in the field of Aseptic Processing and Containment for Pharmaceutical Industries. It designs and manufactures customized isolation technology equipment for pharmaceutical, biotech and chemical applications.
Its containment solutions range from isolators that handle highly active principles or excipients to multi-stage isolators for chemical synthesis or laboratory operations. Its asepsis offerings include isolators designed for sterility tests and formulation of sterile drugs, isolators or RABs integrated into filling lines, and dedicated solutions for Regenerative Medicine applications.
Comecer products are known and used in hospitals, universities, research centers, pharmaceutical companies, cell factories and large industrial groups worldwide.
CPC (Colder Products Company) is the leader in single-use connection technology, offering a wide variety of connectors for biopharmaceutical manufacturing. Innovative, flexible designs easily combine multiple components and systems including process containers, tubing manifolds, transfer lines, bioreactors and other bioprocess equipment. Robust single-use connectors maintain media sterility and integrity while improving production yields, decreasing time to market and reducing costs. The company’s well-known AseptiQuik® and MicroCNX connectors provide quick and easy sterile connections even in non-sterile environments. Learn more about these connectors and our entire portfolio at cpcworldwide.com/bio. Connect with confidence with CPC, an operating company within Dover Corporation.
With over 50 years of experience, we understand the logistics, applications, and requirements that the specialty pharmacy industry faces. We are supporting the temperature-sensitive supply chain requirements of the COVID-19 vaccine with the industry’s broadest portfolio of single-use and reusable systems. The Utilization Review Accreditation Commission’s version 4.0 (URAC) has a mandatory requirement on component testing prior to desktop submission, and accreditation requiring qualification testing of temperature-sensitive packaging designs to be used by the dispensing specialty pharmacy. Not only will our highly trained professionals guide you through these URAC qualification processes, but our cutting-edge ISO 9001:2015, ISTA-certified, cGMP-compliant lab can do the testing for you. We offer compliance documentation for regulatory and accreditation audits, as well as PQ study kits and services. Our Rx family of shipping systems are designed specifically for last mile distribution – specialty pharmacies, mail-order pharmacies, and drug sampling programs. These solutions meet ISTA 7E summer and winter qualifications and are pre-qualified for multiple temperature ranges. Our superior pre-qualified solutions enable the pharmaceutical industry to meet their temperature, regulatory, cost-per-dose, and compliance challenges head on to get their products to those who need them most.
Cold Chain Platform (CCP) is 100% focused on cold chain and logistics in the bio-pharmaceutical, life science, and healthcare industries. CCP shares global cold chain and logistics information and valuable resources to help companies acting in the pharmaceutical space find the right cold chain and logistics partners for their supply chain management.
Website: www.coldchainplatform.com
ABOUT CHIME BIOLOGICS
Chime Biologics, a China-based, world-class Contract Development and Manufacturing Organization (CDMO), providing customer-centric and cost-effective services for timely premier-quality biopharmaceutical development and manufacturing. We provide one stop comprehensive solution supporting our customers from early-stage biopharmaceutical development through late-stage clinical and commercial manufacturing, catering to the evolving needs of the dynamic biopharmaceutical industry. We pledge to make world-class biopharmaceuticals affordable and accessible to all patients globally through manufacturing innovation, and empowering therapeutic advancement for improvement of human health.
With our State-of-the-art facility and in-house world class expert team, we are committed for excellence upholding highest degree of integrity. We are ISO 14001:2015 and ISO 45001:2018 certified. Our World’s first GE KuBio facility is located at Wuhan’s BioLake biotech industry development zone of China, with clear path to expand the total capacity up to 140,000+ in the near future.
CONTACT
Email:bd@chimebiologics.com
Phone:+86 27 8787 9208
ChemPartner is science-based, technology driven global CRO/CDMO research innovation engine with a broad portfolio of services spanning discovery, development, and manufacturing in both small and large molecule therapeutics, including discovery chemistry, biology, pharmacology, DMPK, and exploratory toxicology as well as biologics discovery, development, and CMC.
Website:
Since 1997, CHAYON Laboratories Inc. has been introducing the latest technologies and products for life sciences and other related research areas. With its 25 years of service experience and professional knowledge, CHAYON continues to evolve in the rapidly changing field along with the leading scientists and researchers.
Based on the decades of systematic support by our in-house Technical Sales & Application Scientists, CHAYON is focused on providing unrivaled drug development/discovery services in the Drug Discovery area. In addition, CHAYON is leading the market in various research fields by supplying most up-to-date molecular and cell biology related products, as well as pre-clinical imaging and other automation equipment that incorporate the latest technologies.
Aside from the scientific support and its product portfolio, CHAYON is also known for providing preeminent customer satisfaction in all cases and projects; utilizing its own global standard distribution center for systematic logistics, and field support with internationally trained in-house service engineers.
Finding new possibilities and discovering the future is the value pursued by CHAYON for many years, and we believe that value may only become tangible by the hands of researchers. CHAYON Laboratories will be with researchers to realize our value and their mission.
Chayon homepage:
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe.
The drug research and development process is highly complex, yet essential for delivering safe and effective therapies to patients. Even though the process is well defined, drug development programs are fundamentally different for each product.
Website: https://www.criver.com
Causeway Sensors uses nanotechnology to provide better candidate selection during drug development. The company spun-out after years of high-impact research at Queen’s University Belfast. Our unique nanochip platform brings real-time, label-free kinetic analysis to areas of biotherapeutic production where such data cannot currently be collected. More data at critical points of production helps pharma companies ensure that only the best drug candidates progress to clinical trials. The platform can be incorporated into a multitude of form factors, ranging from a high-throughput screening instrument to an in-line cell culture monitoring tool.
Catalent Biologics has 20+ years’ experience in development, manufacturing, and analytical services for new biological entities, gene therapies, biosimilars, and antibody-drug conjugates. Catalent Biologics has worked with 600+ mAbs and 80+ proteins, with 12 marketed products using GPEx® cell line engineering technology, 25+ commercially-approved products through fill/finish and 40+ active clinical and commercial gene therapy programs.
With tailored solutions for clinical through commercial supply, Catalent Biologics brings better biologic treatments to patients, faster.
For more information, please visit: https://biologics.catalent.com/
Canton biologics is an international technology-based biopharmaceutical CRDMSO company with seven R&D and manufacturing centers around the world. With proprietary High-Titer cell lines(CHO K1/CHO-DG44/GLYCOEXPRESS, over 20g/L), complex protein high expression ability, and production capacity meeting international standards, we have been highly praised by customers.Our major technological breakthroughs have been made in IgMaxTM Expression Platform, IgMasterTM Process Platform, CHO-Rise® Proprietary expression medium, C-BoostTM Intensified Fed-batch Platform, Formulation technology (Lyophilization, Vaccine, nasal spray, lnhalation, Eye drops and High concentration formulation)and analysis. As a highly efficient company, we have created a new record that from DNA to CMC in only 7 months, which has played an important role in the rapid advancement of customers’ products to clinical practice.In addition, we have 12+4 manufacturing lines complying with China, US and EU GMP standard(50-2000L ,batch, fed-batch, perfusion) for DS and DP manufacturing.
Incorporated in 2009, CanSinoBIO (SSE: 688185, HKEX: 06185) commits to provide high-quality, innovative, and accessible vaccines for global public health security. It possesses five integrated platform technologies upon which the company has established a robust pipeline of 17 vaccines preventing 12 diseases, including the world’s initial vaccine for Ebola virus disease Ad5-EBOV, the Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) approved in over 10 countries and granted EUL by the WHO, the Group A and Group C Meningococcal Conjugate Vaccine (CRM197) Menphecia and the Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) Menhycia approved by NMPA in China. Recently, our pioneering inhaled COVID-19 vaccine Convidecia Air has been approved as booster dose in China. Additional information can be found online at www.cansinotech.com.
Centre for Cellular and Molecular Platforms (C-CAMP) is India’s premier innovation and technology hub and one of the largest and most vibrant life sciences incubators in the country. C-CAMP has directly funded, incubated and mentored 350+ start-ups over half a decade and is connected to over 2000 start-ups and entrepreneurs across the country in healthcare, agriculture and environment. C-CAMP has established 15 state-of-the-art technology platforms for facilitating cutting-edge research in the biosciences which have supported 230+ publications. C-CAMP is an initiative supported by Govt of India agencies including Department of Biotechnology, Department of Science & Technology, NITI Aayog-AIM, Ministry of Electronics and Information Technology, Startup India and Department of IT, BT, S&T Government of Karnataka. It has several international partnerships spread across US, UK, Netherlands, Denmark, Switzerland, Japan, Brazil and Israel.
Founded in 1993, Brand Institute (BI) was created on this principle: provide the highest quality name development services, produced and presented by the most experienced professionals, in a timely manner, and at a competitive price. As we strive to deliver industry-leading nomenclature services, we are constantly adapting to our clients’ needs to deliver greater value and successful outcomes.
Boehringer Ingelheim BioXcellence TM is a one of the leading biopharmaceutical contract manufacturers in the world. As a pioneer in biomedical technology, Boehringer Ingelheim started the research and production of biologics in the 1960s with our ground-breaking work on interferons. Since then, we have successfully delivered 39 biopharmaceuticals to the global market, bringing better health to more patients. As the industry leader, Boehringer Ingelheim have partnered with diverse global players, including Top 20 pharma giants, biotech companies, and start-ups. Now Boehringer Ingelheim brought its 30 years-plus of experience into China to establish the biopharmaceutical manufacturing service at global standard. We are committed to supply world-class quality biopharmaceuticals to the global market via our facility in Shanghai, China.
More information please visit：http://www.bioxcellence.com/
Bioworkshops is a full-service CDMO focused on antibody products. We take candidate molecules from DNA sequence through to GMP drug product, meeting requirements of the major Regulatory Authorities, and we do it quickly.
Our services feature:
We operate four GMP cell culture suites with total capacity of 14,000L and three aseptic drug product filling lines for liquid in vials, lyophilized products, and prefilled syringes or cartridges up to 100,000 units per batch.
Merck is a leading science and technology company. Our BioReliance® biosafety testing, viral clearance and analytical development services deliver risk-mitigating solutions with technical and regulatory expertise. We partner with clients through the product cycle, from early pre-clinical development through licensed production, to help ensure the safety of the world’s therapeutics. Our strength is our people, and with 75+ years of trusted biosafety and regulatory expertise.
Safety is Everything
Your Trusted Biologics Testing Partner of Choice for Innovative Biosafety Testing, Viral Clearance & Analytical Developments
BioPharma Asia aims to keep its readers abreast of all developments in Manufacturing, Development, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles and webinars written and presented by the most respected authors/presenters associated with only end-user companies. So, ensuring the information is always guaranteed to remain timely, informative, and unbiased.
Bioneer is an innovative Danish specialty CRO/CMO, creating customized research service solutions to meet our clients’ needs. We help you develop and produce your promising early drug candidates from as early on as their inception and generate key early insights into their mechanisms, efficacy, and safety. A trusted strategic R&D partner to biotech and pharmaceutical companies since 1982, we bring value with our unique know-how and advanced technologies. Visit here: www.bioneer.dk
Pharmaceutical industries have stringent regulations when it comes to quality and safety. In order for businesses to remain competitive in this industry, they need accurate and fast microbial contamination detection solutions that are adaptable and cost-effective. bioMérieux helps the pharmaceutical and healthcare industries unlock greater value from their organizations through a complete line of diagnostic solutions that enable more rapid, consistent results. Reliable and quick results improve safety, enhancing your brand protection, and maintenance of safer pharmaceutical products. bioMérieux solutions protect your product quality.
https://www.biomerieux.com/corp/en/our-offer/pharmaceutical-quality-control.html
BioEngine is a leading cell culture media company founded in 2014 in Shanghai, China. BioEngine specializes in high-density, serum-free suspension culture of animal cells and provides biopharmaceutical companies with premium one-stop services from the development and optimization of the cell culture process, and medium formulation design to media processing and manufacturing.
With more than 30 years of experience and expertise in animal cell culture process and bioreactor engineering, the founding team of BioEngine has successfully developed nearly 100 types of catalog serum-free media. These media have been extensively utilized in over 100 clinical projects in the biopharmaceutical industry, including antibodies, vaccines, and stem cell/cell therapy. BioEngine has also provided cell culture technology services for numerous projects, earning recognition for several “first in China” and “world’s first” achievements.
BioEngine’s Phase II production base achieved full-scale production in 2021. The production base is a state-of-the-art facility built in compliance with the ISO13485:2016 quality management system and GMP requirements. It implements the LSS Lean 6 Sigma system for production management, enabling the construction of large-scale low-temperature Cone Mix/ Pin Milling processes with capacities ranging from thousands to hundreds of thousands of liters. The facility has a maximum batch size of 100,000 liters and an annual production capacity of 55 million liters of powder culture media and 250,000 liters of liquid culture media.
BioEngine is committed to being the most reliable cell culture partner in the world.
Biocair is a global GDP logistics specialist with over 35 years of experience in the pharmaceutical, biotechnology and life sciences sectors.
The company has built up a unique, client-centric approach by employing scientists in front-line logistics positions and assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance. Biocair focuses on providing the most comprehensive time-sensitive and temperature-controlled logistics services available whilst delivering flexible, tailored, cost effective solutions to all clients.
The Biocair network operates 24/7 in over 160 countries across Europe, Africa, Asia and the Americas.
Bio-Rad Laboratories is a leading provider to the life science and clinical diagnostics markets where the company’s products are used for scientific discovery, drug development, and biopharmaceutical production. Bio-Rad’s long-lasting customer relationships foster the company’s research and development efforts and inspire the introduction of innovative products and solutions that accelerate the discovery process and improve healthcare. The Protein Purification Business, part of the Life Science Group at Bio-Rad, provides researchers with the chromatography tools they need to isolate and purify proteins from discovery through clinical trials into bioprocess manufacturing. With more than 60 years of purification experience, Bio-Rad continues to expand solutions to streamline the drug discovery and development process.
Bio-Rad Laboratories, Inc.
Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect™ chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.
For more information, visit https://www.berkeleylights.com/
Primary contact: Maybelline Giam/Yu Sun
Email: Maybelline/Giam@Berkeleylights.com Yu.Sun@Berkeleylights.com
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
For more information on BD, please visit bd.com or connect with us on LinkedIn at
www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson
Bausch+Ströbel is a trusted and experienced supplier to the pharmaceutical industry specializing in filling and packaging systems. B+S filling and packaging lines are used worldwide to fill syringes, vials, cartridges and ampoules with high-grade liquid and powder pharmaceutical products. Applications range from cleaning and sterilization to labelling and syringe assembly. In addition to designing and building systems tailored to customer specifications, Bausch+Ströbel provide a wide range of specialized services aimed at ensuring system reliability and productivity.
At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. Our portfolio is organized into six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF has been present in Singapore since 1978, supplying customers from various industries, including chemicals, construction, electronics, personal care, and health and nutrition. The company today operates four production facilities in Singapore, as well as Human Nutrition Application Lab Asia Pacific for its nutrition and health business. BASF posted sales to customers in Singapore of about €312 million in 2021 and had 505 employees as of the end of the year.
Aventior is a leading global technology company at the forefront of the digital revolution focused on building AI based automation solutions for Manufacturing, CMC, MS&T and QA for Pharma and Biopharma companies.
Our proprietary CPV-Auto™ platform is designed to automate data collection, processing, storage, and analysis of preclinical, clinical and manufacturing data. The platform eliminates the need for manual data entry and enables a 15X faster turnaround to access Critical Production Parameters (CPP), expediting decision-making process. It seamlessly converts paper batch records into a structured, standardized format, extracting valuable information from printed(and handwritten) text, numbers, date fields, notes, and more. Operating as a Data-as-a-Service(DaaS) Platform, CPV-Auto™ ensures robust security and compliance with GxP standards and FDA 21 CFR Part 11 regulations.
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development, and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.
For more information, please visit: avantorsc
ATUM is a fully integrated CRDO (Contract Research Development Organization) biotechnology industry leader who over the last two decades has served our clients by delivering the highest quality Gene Design & Gene Synthesis, Protein Production, Protein Engineering, Cell Line development, using our own proprietary Leap-In TransposaseÒ and Master Cell Banking. With a state-of-the-art machine learning platform, we take you from sequence to MCB with a click of the button. ATUM provides a continual commitment to innovation where our services are built on bioengineered solutions to bring speed to market, supporting you from pre-clinical through IND. Contact us today for more information at atum.bio.
website – https://www.atum.bio/
At Astrea Bioseparations every detail matters as we work to create tailored solutions that streamline bioprocesses from research through commercial phases. We actively support customers with products and services that enable them to bring next-generation therapies to the market to treat and cure diseases
Asahi Kasei Bioprocess is the global market leader in virus filtration, with its Planova™ virus removal filters having an unrivaled 30-year history of trusted use in the production of biotherapeutics. We aim to provide “Assurance Beyond Expectation” to pharmaceutical companies in the form of innovative yet exceptionally reliable bioprocess consumables, equipment, and support services, to help them safely and efficiently produce medicines that patients can trust.
For more information, please visit: https://www.ak-bio.com/
ArcticZymes pioneered the first Salt Active Nuclease for use in Biopharmaceutical manufacturing.
By aligning with the optimal salt balance for host cells, these nucleases enhance both vitality and efficient DNA clearance, turning an obstacle into a strategic advantage. The result is a streamlined workflow, improved product quality, and a new frontier in bioprocessing efficiency.
We continue to develop nucleases that out-performs rivals and that empower you to choose the nuclease that performs best, based on your conditions and your process.
Many design enzymes; we design novel solutions for your conditions.
Contact us to unlock your processes full potential at http://arcticzymes.com
Aptamer Group develops custom affinity binders for use across the life sciences using its proprietary Optimer® platform. Optimer binders can be used as antibody alternatives to offer novel or improved solutions in downstream affinity purification and QC assays to support product release. Optimer binders are removing the barriers to innovation in the life sciences by offering simple resin compatibility, tuneable binding kinetics and high stability. https://aptamergroup.com/
Ami Polymer Pvt. Ltd. is one of the leading manufacturers and suppliers of Biopharmaceuticals and silicone-based products in India . Established in the year 1998 in Mumbai, India, our company has been acclaimed for quality and excellence in the range of products offered. We employ efficient supply chain management system and have committed ourselves to deliver the finest products on time to our valuable customers.
We are an ISO 9001:2015,ISO 14001:2015 & ISO 45000-2018 ,TUV Nord Certified company, having a cleanroom of 25000 sq. feet area, supplying the finest quality range of biopharmaceuticals grade Elastomer Tubing, Reinforced Hoses, Inflatable Gaskets, Extruded & moulded components and single use assemblies as per USFDA standards.
Know more about us at :- www.amipolymer.com
Primary Contact :- Mr. Chandan S./Mrs. Aswathy Nair
Email id :- chandan.s@amipolymer.com/ea@amipolymer.com
Designation :- Sr. Manager Business Devlopment / Sr. Executive International Marketing
Ajinomoto CELLiST Korea Co., Inc. is providing customers with the CELLiST™ series developed based on Ajinomoto’s media manufacturing technology and know-how,
which has been researching serum-free media for over 30 years, through a number of domestic and overseas agencies. https://en.ajinomotocellistkorea.com/
Agilex Biolabs is Australia’s largest and most technologically advanced regulated bioanalytical and toxicology laboratory, providing reliable and defendable data to biotech and pharmaceutical companies worldwide in support of their drug development programs. Our world-class immunoassay and immunobiology laboratories feature state-of-the-art equipment, including Gyrolab xPlore, MSD Quickplex 120, Luminex Magpix, BD FACSymphony A3 flow cytometer and digital droplet PCR for RNA clinical trials, including vaccines and gene therapy trials. Agilex Biolabs also offers a range of toxicology services through its established GLP facility in Brisbane, Australia. We have expertise with all types of molecules, laboratory species, routes of administration, and non-clinical studies. Agilex is a proud member of the Healius network.
AGC Biologics is a global CDMO with seven facilities worldwide providing process development and manufacturing services for protein-based biologics and advanced therapies. From development to clinical trials, to full-scale commercialization, we can help you reach your goals at any stage in the development or manufacturing process. We specialize in the following modalities and substances, mammalian and microbial-based therapeutic proteins, recombinant DNA, plasmid DNA (pDNA), viral vectors, messenger RNA (mRNA), and genetically engineered cells. Our services range from Process Development, Analytical Development, cGMP Manufacturing (both clinical and commercial), Quality Control, and Quality Assurance and Process Validation.
Aeris dynamics packaging was established in Singapore in the year 2001. We are specializing in research, design, test, manufacture, validation, and implementation of cold chain insulated packaging system for the pharmaceuticals, biomedical science, vaccine, clinical trials, medical, diagnostics and healthcare markets.
Aeris now offers it service from 9 locations India, Singapore, Malaysia, South Korea, China, Thailand, Hong Kong, Gulf and Australia. Aeris offers both standard and customize shipping system designed to ensure the integrity upon arrival of sensitive vaccines, drugs enzymes, blood, diagnostic specimens, and other associated products.
Aeris dynamics products are manufactured to cater for industries requirements meeting stringent shipping regulations as well as in reference to the guidance by leading industries and government bodies such as the FDA, WHO, IATA and ISTA.
Our vision is to be the leading global supply partner for cold chain temperature-controlled packaging. Our mission through our product and service excellence by technological innovation is to become the preferred choice of cold chain packaging solutions supply partner.
Advanced Instruments is a global provider of scientific and analytical instruments for the bioprocessing and clinical industries. Since 1955, the company’s innovations have helped organizations improve quality of results, achieve reliable outcomes, and increase workplace productivity. Its newest addition, the Artel portfolio, includes leading analytical instruments, software and services that validate, automate, and calibrate critical liquid handling processes and instrumentation. In the biopharma space, the Solentim portfolio of best-in-class imaging and single-cell deposition technologies enables the clonal isolation, outgrowth, and characterization of the highest value cells for monoclonal antibody upstream development and cell and gene therapy. Its OsmoTECH® line of micro-osmometers are built specifically to support workflows throughout every phase of bioprocessing. Similarly, clinical labs worldwide rely on Advanced Instruments’ innovative solutions for delivery of accurate and timely patient results in their clinical chemistry, microbiology and hematology labs. For more information, visit www.aicompanies.com
Adapt builds cloud-connected data loggers for cold chain monitoring.
Adapt loggers is established to support active cold chain operations with real-time asset intelligence data, which is essential to curb the losses.
Asset tracking, Logistics, Cold-chain, Biopharma, Food, and Cold storage companies use Adapt solutions to track and monitor their operations.
The patented end-to-end monitoring solutions give real-time status reports of the asset’s location, temperature, humidity, tampering, and mishandling
Adapt provides Cloud storage and a Web-App interface for real-time data access and ease of reporting.
URL or link to your website:
AcuraBio Pty Ltd is one of Australia’s most experienced microbial fermentation CDMOs (including microbial recombinant proteins), offering trusted, client-focused services to both domestic and international clients for the past 20 years.
World-class researchers and proven facilities, a streamlined regulatory framework, generous tax incentives, and government funding make Australia a prime location for biotech research.
Leveraging decades of expertise in microbial expression systems, AcuraBio is now adding cGMP pDNA services to its service offering, offering plasmid DNA for therapeutic, vaccine and diagnostic applications including mRNA and viral vector based advanced therapies.
AcuraBio holds the following licenses: TGA (Australian FDA equivalent) license for the manufacture of human therapeutic APIs, APVMA (veterinary equivalent of the TGA) license for manufacture of sterile immunobiological products, OGTR license to produce products from genetically modified organisms (GMOs), and a DAF facility license for import and use of biologic materials.
Additional information about AcuraBio is available at www.acurabio.com.
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in 12 different cities within the United States, Switzerland, Japan and Germany.
Abzena is a leading contract provider of integrated discovery, development and manufacturing services for biologics and antibody drug conjugates (ADCs). Abzena provides the most complete set of solutions in integrated early discovery to mid-phase biotherapeutic and bioconjugation drug development and manufacturing in the biopharmaceutical industry. The company maintains resources around the world, with facilities in the US and UK. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors. For more information, please see www.abzena.com.
The Agency for Science, Technology and Research (A*STAR) is Singapore’s lead public sector R&D agency. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit the economy and society. As a Science and Technology Organization, A*STAR bridges the gap between academia and industry. Our research creates economic growth and jobs for Singapore, and enhances lives by improving societal outcomes in healthcare, urban living, and sustainability. A*STAR plays a key role in nurturing scientific talent and leaders for the wider research community and industry.
For ongoing news, visit www.a-star.edu.sg.
The 3M biopharmaceutical business is a subset of the 3M Separation and Purification Sciences Division which utilizes cutting edge 3M material science that pushes the boundaries of purification, filtration, and separation to support production, processes that change lives, and deliver quality solutions where it matters most.
Our biopharma and materials science expertise can help you improve in-process purity, increase the yield of your product and lower manufacturing costs – so you can focus on bringing life-saving treatments to trial and market
360biolabs, a BioAgilytix company, offers the full spectrum of bioanalytical lab services for small and large molecules in all phases of drug development, with the added benefits that come from conducting your early phase clinical trials in Australia.
As APAC’s most comprehensive speciality laboratory, we provide a single laboratory for all of your global clinical trial requirements. We support pharmacokinetic (PK) analysis (biologics, small molecules, peptides and proteins), a diverse range of pharmacodynamic (PD) endpoints (flow cytometry, biomarkers, molecular assays, ELISPOT, virological endpoints including neutralisation) and central lab services in a quality assured environment (GLP, GCP, ISO / IEC 17025). As BioAgilytix LLC’s Australian subsidiary, we provide a single solution for your global clinical trial requirements with laboratories in USA and Europe as well as Australia.
IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.
© 2023 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.
